https://www.concertai.com/publications/developing-a-pan-cancer-foundation-model-for-digital-patient-representation-and-clinical-prediction-across-real-world-oncology-data2026-08-18https://www.concertai.com/publications/identifying-the-period-of-heightened-risk-for-adrenal-insufficiency-in-patients-with-advanced-non-small-cell-lung-cancer-treated-with-first-line-immune-checkpoint2026-08-18https://www.concertai.com/bloghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Blog%20-%20AI%20in%20Clinical%20Trials.pngBlog - AI in Clinical TrialsBlog - AI in Clinical Trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Blog%20-%2010-20%20Months%20Cut%20Timelines.pngBlog - 10-20 Months Cut TimelinesBlog - 10-20 Months Cut Timelineshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/img-hero-blog@1.5x.jpgimg-hero-blog@1.5ximg-hero-blog@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lightning%20Strikes%20IV-%20Emergy%20Pharama-Patient%20Compat%20(3).pngConcertAI Blog - Lightning Strikes IV- Emergy Pharama-Patient Compat (3)ConcertAI Blog - Lightning Strikes IV- Emergy Pharama-Patient Compat (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lightning%20Strikes%20-%20CARA%20Meet%20ELSA.pngConcertAI Blog - Lightning Strikes - CARA Meet ELSAConcertAI Blog - Lightning Strikes - CARA Meet ELSAhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360%20Blog.pngTranslational360 BlogTranslational360 Bloghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20blog-Precision360-2.pngASCO blog-Precision360-2ASCO blog-Precision360-22026-05-28https://www.concertai.com/publications/2024/03/annual-trends-in-opioid-prescribing-for-patients-pts-with-metastatic-non-small-cell-lung-cancer-mnsclc-cancerlinq-data-analysis-2010-to-2017/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-03https://www.concertai.com/publications/augmenting-external-control-arms-using-bayesian-borrowing-a-case-study-in-first-line-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/blog/2023/02/putting-trial-diversity-in-practice-a-data-driven-approachhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Figure-2png-1.pngFigure-2png-1Figure-2png-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Figure-1-1.pngFigure-1-1Figure-1-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Putting-Trial-Diversity-in-Practice-BLOG-1.pngPutting-Trial-Diversity-in-Practice-BLOG-1Putting-Trial-Diversity-in-Practice-BLOG-12024-03-17https://www.concertai.com/eurekahealth-graphic/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/bg-1.pngbg-1bg-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-03https://www.concertai.com/intelligent-aihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/snapshot-of-methodology.pngsnapshot-of-methodologysnapshot-of-methodologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ecog-imputation-modeling.pngecog-imputation-modelingecog-imputation-modelinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/depiction-of-patient-journey.pngdepiction-of-patient-journeydepiction-of-patient-journeyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/hero-img-intelligent-ai@1.5x.jpghero-img-intelligent-ai@1.5xhero-img-intelligent-ai@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ispor-logo.jpgispor-logoispor-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/risk-prediction-model.pngrisk-prediction-modelrisk-prediction-modelhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/francois_slow-progressors-research_transparent.pngfrancois_slow-progressors-research_transparentfrancois_slow-progressors-research_transparenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/depiction-of-patient-journey-ehr.pngdepiction-of-patient-journey-ehrdepiction-of-patient-journey-ehrhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/depiction-of-patient-journey-predict-survival.pngdepiction-of-patient-journey-predict-survivaldepiction-of-patient-journey-predict-survival2024-04-01https://www.concertai.com/blog/2024/02/randomized-controlled-trials-rcts-and-real-world-outcomes-in-hematological-malignancies-minding-the-gaphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Minding-the-Gap-Blog-Post-Graphic-1.pngMinding-the-Gap-Blog-Post-Graphic-1Minding-the-Gap-Blog-Post-Graphic-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-27https://www.concertai.com/emr3edchttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Scalability%20(Blue).svgScalability (Blue)Scalability (Blue)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Speed%20(Blue).svgSpeed (Blue)Speed (Blue)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Compliance.svgComplianceCompliancehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Efficiency%20(Blue).svgEfficiency (Blue)Efficiency (Blue)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/EMR2EDC%20Banner.pngEMR2EDC BannerEMR2EDC Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/EMR2EDC%20Social%20SQ.pngEMR2EDC Social SQEMR2EDC Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/EMR2EDC%20Image.pngEMR2EDC ImageEMR2EDC Image2025-05-29https://www.concertai.com/publications/real-world-study-on-characteristics-post-nephrectomy-journey-and-outcomes-of-patients-with-early-stage-renal-cell-carcinoma-based-on-risk-groups2026-08-18https://www.concertai.com/intuitionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%20Screengrab.pngSTAR ScreengrabSTAR Screengrabhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20GTM%20Art.pngPrecision GTM ArtPrecision GTM Arthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Screenshot%202025-04-16%20at%201.39.14%20PM.pngScreenshot 2025-04-16 at 1.39.14 PMScreenshot 2025-04-16 at 1.39.14 PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Screengrab.pngSpecialty Data ScreengrabSpecialty Data Screengrabhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20Art.pngPrecision Explorer ArtPrecision Explorer Arthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Engagement%20Platform%20Screengrab.pngPatient Engagement Platform ScreengrabPatient Engagement Platform Screengrabhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20Art.pngPrecision Trials ArtPrecision Trials Arthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20Banner.pngPatient Matching BannerPatient Matching Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/efficiency.svgefficiencyefficiencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20Image.pngPatient Matching ImagePatient Matching Imagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/inclusion_1.svginclusion_1inclusion_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/compliance_1.svgcompliance_1compliance_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2034.svgAsset 34Asset 34https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20Social%20SQ.pngPatient Matching Social SQPatient Matching Social SQ2025-05-29https://www.concertai.com/publications/2024/03/capturing-patient-advance-directives-status-in-a-community-oncology-practice-using-an-electronic-patient-reported-outcomes-epro-system/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/electronic-health-records-ehr-based-machine-learning-ml-approach-to-predict-risk-of-progression-to-metastatic-melanoma-after-initial-diagnosis2026-08-18https://www.concertai.com/concertai-acquires-cancerlinqhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Supporting%20automated%20EMR%20integration%2c%20bringing%20SmartLinQ%20seamlessly%20into%20practices%E2%80%99%20workflows.svgSupporting automated EMR integration, bringing SmartLinQ seamlessly into practices’ workflowsSupporting automated EMR integration, bringing SmartLinQ seamlessly into practices’ workflowshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/A%20Major%20Step%20in%20Transforming%20Cancer%20Care.pngA Major Step in Transforming Cancer CareA Major Step in Transforming Cancer Carehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Jeff%20Elton%2c%20PHD.pngJeff Elton, PHDJeff Elton, PHDhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Making%20clinical%20trials%20participation%20more%20accessible%20and%20less%20burdensome%20through%20ConcertAI%E2%80%99s%20Digital%20Access%20to%20Clinical%20Trial%20(DACT)%20platform.svgMaking clinical trials participation more accessible and less burdensome through ConcertAI’s Digital Access to Clinical Trial (DACT) platformMaking clinical trials participation more accessible and less burdensome through ConcertAI’s Digital Access to Clinical Trial (DACT) platformhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Read%20the%20blog%20by%20Jeff%20Elton%2c%20PhD.pngRead the blog by Jeff Elton, PhDRead the blog by Jeff Elton, PhDhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clifford%20A.Hudis%2c%20MD%2c%20FACP%2c%20FASCO.pngClifford A.Hudis, MD, FACP, FASCOClifford A.Hudis, MD, FACP, FASCOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/CancerLinq%20Initiative%20of.svgCancerLinq Initiative ofCancerLinq Initiative ofhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Developing%20more%20robust%20clinical%20decision%20support%20within%20SmartLinQ.svgDeveloping more robust clinical decision support within SmartLinQDeveloping more robust clinical decision support within SmartLinQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/CancerLinq.pngCancerLinqCancerLinqhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Eric%20P.Winer%2c%20MD%2c%20FASCO.pngEric P.Winer, MD, FASCOEric P.Winer, MD, FASCOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Bolstering%20SmartLinQTM%20to%20include%20new%20data%20sources%20alongside%20the%20robust%20clinical%20data%20currently%20available.svgBolstering SmartLinQTM to include new data sources alongside the robust clinical data currently availableBolstering SmartLinQTM to include new data sources alongside the robust clinical data currently availablehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/View%20Press%20Release%20Button.pngView Press Release ButtonView Press Release Button2024-04-02https://www.concertai.com/publications/survival-outcomes-of-apalutamide-as-a-starting-treatment-impact-in-real-world-patients-with-metastatic-hormone-sensitive-prostate-cancer-oasis2026-08-18https://www.concertai.com/case-study_predictive-patient_transforming-adherencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/casestudy-Predictive-Patient_Transforming-Patient-Adherence_thumbnail-for-content-page-1024x543.pngcasestudy-Predictive-Patient_Transforming-Patient-Adherence_thumbnail-for-content-page-1024x543casestudy-Predictive-Patient_Transforming-Patient-Adherence_thumbnail-for-content-page-1024x543https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/newsroom-oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2026-05-28https://www.concertai.com/blog/ai-in-clinical-trials-from-promise-to-measurable-impacthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Blog%20-%20AI%20in%20Clinical%20Trials.pngBlog - AI in Clinical TrialsBlog - AI in Clinical Trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-05-21https://www.concertai.com/publications/lurbinectedin-vs-an-external-control-arm-in-patients-with-small-cell-lung-cancer2026-08-18https://www.concertai.com/blog/assuring-the-strength-of-oncology-care-for-all-patients-and-all-communitieshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Community%20Oncology%20Viability%20Blog%20(1).pngCommunity Oncology Viability Blog (1)Community Oncology Viability Blog (1)2024-07-12https://www.concertai.com/publications/real-world-analysis-of-a-large-electronic-medical-record-database-of-patients-with-higher-risk-myelodysplastic-neoplasms-hr-mds-treatment-profiles-clinical2026-08-18https://www.concertai.com/publications/the-survival-benefit-of-anti-her2-treatment-in-the-management-of-small-t1mic-t1a-t1b-t1c-node-negative-her2-plus-breast-cancer2026-08-18https://www.concertai.com/patient360https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_8.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_8CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_8https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient360%20v1.pngPatient360 v1Patient360 v12026-05-28https://www.concertai.com/news/concertai-introduces-cadence-suite-delivering-industry-leading-visibility-and-predictive-insights-into-the-patients-journey-for-commercial-teamshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Social/ConcertAI%20Press%20Release%20ConcertAI%20Launches%20Cadence%20Suite-3.pngConcertAI Press Release ConcertAI Launches Cadence Suite-3ConcertAI Press Release ConcertAI Launches Cadence Suite-32026-04-21https://www.concertai.com/publications/real-world-use-of-accelerated-approval-oncology-drugs-subsequently-withdrawn-in-the-united-states-20252026-08-18https://www.concertai.com/publications/real-world-side-effects-of-targeted-therapies-high-throughput-association-studies-leveraging-the-cancerlinq-discovery-lung-cancer-database2026-08-18https://www.concertai.com/publications/machine-learning-ml-on-real-world-data-rwd-of-front-line-1l-metastatic-castration-resistance-prostate-cancer-mcrpc-patients-for-dynamic-prediction-of-time-to-tx2026-08-18https://www.concertai.com/publications/predicting-real-world-overall-survival-for-post-operative-pancreatic-ductal-adenocarcinoma-an-asco-cancerlinq-discovery-analysis2026-08-18https://www.concertai.com/news/2023/02/concertai-hires-jitendra-gupta-as-first-managing-director-of-indiahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/DSCF9509.jpgDSCF9509DSCF9509https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Jitendra-Gupta-Announcement.pngJitendra-Gupta-AnnouncementJitendra-Gupta-Announcement2024-03-06https://www.concertai.com/publications/impact-of-real-world-response-to-first-line-immunotherapy-and-chemotherapy-on-subsequent-treatment-outcomes-in-patients-with-advanced-or-metastatic-non-small-cell-lung2026-08-18https://www.concertai.com/translational360https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_5.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_5CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360%20v1.pngTranslational360 v1Translational360 v1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-06-03https://www.concertai.com/precision-gtmhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PGTM%20-BiomarkerTesting.pngPGTM -BiomarkerTestingPGTM -BiomarkerTestinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PGTM%20-CompetitiveCrossTabs.pngPGTM -CompetitiveCrossTabsPGTM -CompetitiveCrossTabshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PGTM%20-CohortBuilder.pngPGTM -CohortBuilderPGTM -CohortBuilderhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20GTM%20IMG.pngPrecision GTM IMGPrecision GTM IMGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_11.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_11CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_11https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PGTM%20-PatientJourney2.pngPGTM -PatientJourney2PGTM -PatientJourney2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PGTM%20-CareGaps.pngPGTM -CareGapsPGTM -CareGapshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PGTM%20-PracticeAnalyzerAgent%20-snippingtool%201.pngPGTM -PracticeAnalyzerAgent -snippingtool 1PGTM -PracticeAnalyzerAgent -snippingtool 12026-05-28https://www.concertai.com/media-hubhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-Podcast-Banner-Plug.pngConcertAI-Podcast-Banner-PlugConcertAI-Podcast-Banner-Plughttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/img-hero-blog@1.5x.jpgimg-hero-blog@1.5ximg-hero-blog@1.5x2024-04-01https://www.concertai.com/publications/a-us-based-retrospective-observational-study-of-biomarker-testing-patterns-across-lines-of-therapy-in-patients-with-metastatic-colorectal-cancer2026-08-18https://www.concertai.com/concertai-at-asco-2022/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Concert%20Ai%20at%20ASCO.jpgConcert Ai at ASCOConcert Ai at ASCOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Generating%20Multi-modal%20Real-world%20Data.svgGenerating Multi-modal Real-world DataGenerating Multi-modal Real-world Datahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20at%20ASCO.svgConcertAI at ASCOConcertAI at ASCOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Asset.svgAssetAssethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Advancing%20Equity%20&%20Trial%20Diversity.svgAdvancing Equity & Trial DiversityAdvancing Equity & Trial Diversityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us.svgMeet-With-UsMeet-With-Ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Check%20out%20our%20Blog%20from%20ASCO%202022.jpgCheck out our Blog from ASCO 2022Check out our Blog from ASCO 2022https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Accelerating%20Study%20Design%20&%20Execution.svgAccelerating Study Design & ExecutionAccelerating Study Design & Executionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)2024-04-02https://www.concertai.com/publications/prognosis-and-conditional-survival-among-women-with-newly-diagnosed-ovarian-cancer2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-clinical-outcomes-post-standard-of-care-soc-among-patients-pts-with-metastatic-non-small-cell-lung-cancer-mnsclc-with-and-without2026-08-18https://www.concertai.com/publications/an-adjusted-treatment-comparison-comparing-amivantamab-versus-real-world-clinical-practice-in-europe-and-the-united-states-for-patients-with-advanced-non-small-cell2026-08-18https://www.concertai.com/request_a_demohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-05-27https://www.concertai.com/blog/lightning-strikes-when-cara-met-elsahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lightning%20Strikes%20-%20CARA%20Meet%20ELSA.pngConcertAI Blog - Lightning Strikes - CARA Meet ELSAConcertAI Blog - Lightning Strikes - CARA Meet ELSAhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/image-png-3.pngimage-png-3image-png-3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/image-png-4.pngimage-png-4image-png-4https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-08-21https://www.concertai.com/artificial-intelligence-health-equity/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artificial-Intelligence-Health-Equity-Banner-2.pngArtificial-Intelligence-Health-Equity-Banner-2Artificial-Intelligence-Health-Equity-Banner-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/specialty-data-aggregationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Social%20SQ.pngSpecialty Data Social SQSpecialty Data Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2025.svgAsset 25Asset 25https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Contract%20Compliance%20Tracking.pngSDA - Contract Compliance TrackingSDA - Contract Compliance Trackinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Aggregation%20Cover.pngSpecialty Data Aggregation CoverSpecialty Data Aggregation Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2023.svgAsset 23Asset 23https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Speed.pngSDA - SpeedSDA - Speedhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Multi-Partner%20Data.pngSDA - Multi-Partner DataSDA - Multi-Partner Datahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Market%20Access.pngSDA - Market AccessSDA - Market Accesshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2024.svgAsset 24Asset 24https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Aggregation%20Banner.pngSpecialty Data Aggregation BannerSpecialty Data Aggregation Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2026.svgAsset 26Asset 262025-09-25https://www.concertai.com/eventshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ESMO%202026.pngESMO 2026ESMO 2026https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_6.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_6CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_6https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RSNA%202026-2.pngRSNA 2026-2RSNA 2026-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-06-04https://www.concertai.com/blog/2023/04/the-concertai-podcast-exploring-the-future-of-clinical-trials-feat-bristol-myers-squibbs-marissa-co-gaelan-ritterhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/BMS-Podcast-Day-Image-Sml-1.pngBMS-Podcast-Day-Image-Sml-1BMS-Podcast-Day-Image-Sml-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-17https://www.concertai.com/news/2023/02/richard-yates-concertais-first-chief-information-officerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Richard-Yates-CIO-Announcement.pngRichard-Yates-CIO-AnnouncementRichard-Yates-CIO-Announcementhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-06https://www.concertai.com/publications/real-world-characteristics-and-outcomes-of-patients-with-third-line-or-later-metastatic-colorectal-cancer-magnetic-101-study-results2026-08-18https://www.concertai.com/publications/implementing-a-braf-biomarker-electronic-clinical-quality-measure-in-cancerlinq2026-08-18https://www.concertai.com/publications/electronic-health-record-ehr-based-machine-learning-ml-to-predict-disease-recurrence-after-surgical-resection-of-early-stage-non-small-cell-lung-cancer-ensclc2026-08-18https://www.concertai.com/publications/real-world-risk-of-recurrence-and-treatment-outcomes-with-adjuvant-endocrine-therapy-in-patients-with-stage-ii-iii-hr-plus-her2-early-breast-cancer2026-08-18https://www.concertai.com/publications/outcomes-among-patients-with-mantle-cell-lymphoma-post-covalent-btk-inhibitor-therapy-in-the-united-states-a-real-world-electronic-medical-records-study2026-08-18https://www.concertai.com/why-were-differenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NeoGenomics.svg.pngNeoGenomics.svgNeoGenomics.svghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CarisLS_Color_Primary_Logo.webpCarisLS_Color_Primary_LogoCarisLS_Color_Primary_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Guardant%20Health.svgGuardant HealthGuardant Healthhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Nvidia_logo.svgNvidia_logoNvidia_logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Foundation%20Medicine%20Logo.svgFoundation Medicine LogoFoundation Medicine Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cara%20Image%201.pngCara Image 1Cara Image 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Map%201%20Why%20Were.pngMap 1 Why WereMap 1 Why Werehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Updated%20Image%20for%20Why%20Were%20v2.pngUpdated Image for Why Were v2Updated Image for Why Were v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amazon_Web_Services_Logo.svgAmazon_Web_Services_LogoAmazon_Web_Services_Logo2026-08-07https://www.concertai.com/news/2023/01/concertai-presentation-at-jp-morgan-2023https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/JP-Morgan-PR-Low-Res-v2.pngJP-Morgan-PR-Low-Res-v2JP-Morgan-PR-Low-Res-v22024-03-06https://www.concertai.com/cancerlinq-suite_oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision.svgPrecisionPrecisionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/New%20FDA%20Approvals%20(RxLinQ)%20Cover.pngNew FDA Approvals (RxLinQ) CoverNew FDA Approvals (RxLinQ) Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Efficiency.svgEfficiencyEfficiencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PatientLinQ-1.pngPatientLinQ-1PatientLinQ-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SmartLinQ%20Banner.pngSmartLinQ BannerSmartLinQ Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TriaLinQ.pngTriaLinQTriaLinQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SmartLinQ%20Homepage.pngSmartLinQ HomepageSmartLinQ Homepagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Insight.svgInsightInsighthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RxLinQ.pngRxLinQRxLinQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SmartLinQ%20Social%20SQ%20v2.pngSmartLinQ Social SQ v2SmartLinQ Social SQ v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Equity.svgEquityEquityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Quality%20Measures.pngQuality MeasuresQuality Measures2026-05-28https://www.concertai.com/publications/identification-of-biomarkers-for-early-progression-in-muscle-invasive-bladder-cancer-mibc-using-real-world-data2026-08-18https://www.concertai.com/who-we-arehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Cover%202%20(1).pngConcertAI Cover 2 (1)ConcertAI Cover 2 (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_3217.jpgIMG_3217IMG_3217https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF4415-2.jpgDSCF4415-2DSCF4415-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/shared%20image%20(43).jpgshared image (43)shared image (43)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Social/ITEM%20Booth%202026-crop.jpgITEM Booth 2026-cropITEM Booth 2026-crophttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF0939.jpgDSCF0939DSCF0939https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_9606.jpgIMG_9606IMG_9606https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_1586-2.jpgIMG_1586-2IMG_1586-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/FullSizeRender-5.jpgFullSizeRender-5FullSizeRender-5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF4670-Enhanced-NR.jpgDSCF4670-Enhanced-NRDSCF4670-Enhanced-NRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF7746.jpgDSCF7746DSCF7746https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/social-suggested-images/20250531_084051-crop.jpg20250531_084051-crop20250531_084051-crophttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Group%20Photo.pngGroup PhotoGroup Photohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SCOPE%202026%20Team%20Photo-2.jpgSCOPE 2026 Team Photo-2SCOPE 2026 Team Photo-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/shared%20image%20(41).jpgshared image (41)shared image (41)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/processed-EB263BCB-F8E5-4B3F-A8B3-310154CCDE1C-75C3835F-B945-4029-88A4-73EF1025FDC7-2.jpgprocessed-EB263BCB-F8E5-4B3F-A8B3-310154CCDE1C-75C3835F-B945-4029-88A4-73EF1025FDC7-2processed-EB263BCB-F8E5-4B3F-A8B3-310154CCDE1C-75C3835F-B945-4029-88A4-73EF1025FDC7-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_3850.jpgIMG_3850IMG_3850https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/shared%20image%20(90).jpgshared image (90)shared image (90)2026-07-16https://www.concertai.com/publications/management-of-severe-immune-related-adverse-events-and-outcomes-in-patients-with-advanced-non-small-cell-lung-cancer-receiving-immune-checkpoint-inhibitors2026-08-18https://www.concertai.com/publications/a-real-world-study-of-us-patients-with-metastatic-ovarian-fallopian-tube-and-peritoneal-cancer-mofpc-using-integrated-electronic-health-records-ehr-and-claims-datasets2026-08-18https://www.concertai.com/news/concertai-announces-leadership-transition-to-accelerate-ai-innovation-and-growthhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Eron%20Kelly%20PR.pngEron Kelly PREron Kelly PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-05-01https://www.concertai.com/publications/survival-impact-of-adjuvant-chemotherapy-regimens-for-small-t1mi-a-b-node-negative-pn0-triple-negative-breast-cancer-tnbc2026-08-18https://www.concertai.com/blog/the-biomedical-innovation-that-is-here-precision-oncologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/We%20Know%20Lung%20Cancer%20Screening%20Saves%20Lives%20How%20Can%20We%20Assure%20Access-2.pngWe Know Lung Cancer Screening Saves Lives How Can We Assure Access-2We Know Lung Cancer Screening Saves Lives How Can We Assure Access-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-11-12https://www.concertai.com/publications/real-world-outcomes-in-patients-pts-with-metastatic-triple-negative-breast-cancer-mtnbc-treated-with-sacituzumab-govitecan-sg-in-2l-plus-in-the-united-states-us2026-08-18https://www.concertai.com/publications/real-world-clinical-characteristics-treatment-patterns-and-clinical-outcomes-in-us-patients-with-stage-i-iii-resected-nsclc-without-known-egfr-mutations-the-resect-study2026-08-18https://www.concertai.com/publications/biomarkers-of-response-in-patients-with-gastric-gastroesophageal-junction-adenocarcinoma-gea-treated-with-telisotuzumab-adizutecan2026-08-18https://www.concertai.com/publications/evaluating-clinical-trial-inclusion-exclusion-criteria-from-claims-using-generative-artificial-intelligence2026-08-18https://www.concertai.com/consulting-and-analytic-serviceshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Flexible.svgFlexibleFlexiblehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Efficient%20(Pink).svgEfficient (Pink)Efficient (Pink)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Gold%20Standard.svgGold StandardGold Standardhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAS%20-%20ECA.pngCAS - ECACAS - ECAhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Consulting%20&%20Analytic%20Services.pngConsulting & Analytic ServicesConsulting & Analytic Serviceshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAS%20-%20Comparative%20Cohorts.pngCAS - Comparative CohortsCAS - Comparative Cohortshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Consulting%20&%20Analytics%20Banner.pngConsulting & Analytics BannerConsulting & Analytics Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Consulting%20&%20Analytics%20Social%20Image.pngConsulting & Analytics Social ImageConsulting & Analytics Social Imagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAS%20-%20Feasibility.pngCAS - FeasibilityCAS - Feasibilityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Consultative.svgConsultativeConsultative2025-05-30https://www.concertai.com/publications/comparative-effectiveness-of-abiraterone-and-enzalutamide-in-the-first-line-treatment-of-metastatic-castration-resistant-prostate-cancer-mcrpc-a-retrospective-cohort2026-08-18https://www.concertai.com/publications/real-world-outcomes-among-patients-with-metastatic-colorectal-cancer-treated-first-line-with-a-bevacizumab-biosimilar-bevacizumab-awwb2026-08-18https://www.concertai.com/news/2023/01/caris-and-concertaihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/CARIS-Partnership-Lo-Res-v2.pngCARIS-Partnership-Lo-Res-v2CARIS-Partnership-Lo-Res-v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-06https://www.concertai.com/publications/clinical-characteristics-and-outcomes-of-black-patients-with-multiple-myeloma-compared-with-other-races2026-08-18https://www.concertai.com/publications/streamline-retrospective-cohort-study-of-fms-like-tyrosine-kinase-3-mutated-acute-myeloid-leukemia-real-world-treatment-patterns-and-clinical-outcomes-of-patients-in2026-08-18https://www.concertai.com/publications/2024/03/using-artificial-intelligence-to-improve-capture-of-metastatic-breast-cancer-bc-status-in-electronic-health-records-ehr/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/treatment-patterns-and-outcomes-among-patients-with-egfr-mutant-advanced-nsclc-in-the-frontline-and-post-osimertinib-settings2026-08-18https://www.concertai.com/publications/immune-related-adverse-events-of-anti-pd-l-1-immunotherapy-with-and-without-chemotherapy-in-patients-with-advanced-non-small-cell-lung-cancer-a-real-world-evidence2026-08-18https://www.concertai.com/concertai-at-esmo-2022/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Advancing%20Equity%20&%20Trial%20Diversity.svgAdvancing Equity & Trial DiversityAdvancing Equity & Trial Diversityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ESMO.pngESMOESMOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Asset.svgAssetAssethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Generating%20Multi-modal%20Real-world%20Data.svgGenerating Multi-modal Real-world DataGenerating Multi-modal Real-world Datahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ESMO.svgESMOESMOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us.svgMeet-With-UsMeet-With-Ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Accelerating%20Study%20Design%20&%20Execution.svgAccelerating Study Design & ExecutionAccelerating Study Design & Executionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimization2024-04-03https://www.concertai.com/publications/unmet-need-in-heavily-pre-treated-patients-with-hr-plus-her2-metastatic-breast-cancer-mbc-in-the-us-a-concertai-analysis2026-08-18https://www.concertai.com/publications/diagnosed-with-advanced-prostate-cancer-a-population-based-cohort-from-national-oncology-practices2026-08-18https://www.concertai.com/news/concertai-introduces-predictive-and-generative-ai-solutions-powered-by-multi-modal-real-world-data-key-partnerships-cara-ai-and-more-at-the-2024-asco-annual-meetinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%202024%20PR%20-%20General.pngASCO 2024 PR - GeneralASCO 2024 PR - Generalhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-05-31https://www.concertai.com/publications/effect-of-covid-19-vaccination-status-on-adverse-events-and-outcomes-in-advanced-non-small-cell-lung-cancer-ansclc-patients-treated-with-immunotherapies2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-in-patients-with-mycosis-fungoides-or-sezary-syndrome-treated-with-mogamulizumab-in-the-united-states-a-retrospective-database-analysis2026-08-18https://www.concertai.com/news/concertai-guardant-health-collaborate-to-form-first-data-as-a-servicehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20and%20Guardant%20Health.pngConcertAI and Guardant HealthConcertAI and Guardant Health2025-01-16https://www.concertai.com/concertai-patient-solutions-factsheetshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/the-survival-benefit-of-adjuvant-trastuzumab-with-or-without-chemotherapy-in-the-management-of-small-t1mic-t1a-t1b-t1c-node-negative-her2-plus-breast-cancer2026-08-18https://www.concertai.com/publications/evaluating-the-impact-of-performance-status-criteria-on-minority-eligibility-for-oncology-clinical-trials2026-08-18https://www.concertai.com/investorshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/declaration%20(1).pngdeclaration (1)declaration (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Sixth%20Street%20(3).pngSixth Street (3)Sixth Street (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_3.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_3CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Alliance%20Bernstein%20PCI%20(1).pngAlliance Bernstein PCI (1)Alliance Bernstein PCI (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Sixth-Street-16x9-1.webpSixth-Street-16x9-1Sixth-Street-16x9-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_2.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_2CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Maverick%20Ventures.pngMaverick VenturesMaverick Ventures2026-05-28https://www.concertai.com/webinar_4_6_racial-equity-in-study-designhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Webinar_4_13_Racial-Equity-in-Study-Design_LP.pngWebinar_4_13_Racial-Equity-in-Study-Design_LPWebinar_4_13_Racial-Equity-in-Study-Design_LPhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Jeremy-Miller_circle_transparent-background-2048x2048.pngJeremy-Miller_circle_transparent-background-2048x2048Jeremy-Miller_circle_transparent-background-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-29https://www.concertai.com/news/24-executive-healthcare-ai-predictions-trends-to-watch-in-2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Featured%20Article%20-%20HIT.pngFeatured Article - HITFeatured Article - HIThttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-01-21https://www.concertai.com/publications/ai-enabled-clinical-trial-framework-for-end-to-end-site-recommendation-and-enrollment-projection2026-08-18https://www.concertai.com/publications/biomarker-prevalence-in-us-patients-with-gastric-gastroesophageal-junction-adenocarcinoma-gea-from-real-world-data2026-08-18https://www.concertai.com/news/2023/12/asco-and-concertai-expand-existing-collaboration-to-build-cancerlinq-into-the-leading-healthcare-learning-and-research-network-in-oncologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/CLQ-Social-v3-1024x536.pngCLQ-Social-v3-1024x536CLQ-Social-v3-1024x5362024-03-06https://www.concertai.com/translational360_oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360%20Homepage%20Image%202025.pngTranslational360 Homepage Image 2025Translational360 Homepage Image 2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360%20Banner.pngTranslational360 BannerTranslational360 Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Flexible%20(Purple).svgFlexible (Purple)Flexible (Purple)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Comprehensive%20(Purple).svgComprehensive (Purple)Comprehensive (Purple)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Real%20World%20(Purple).svgReal World (Purple)Real World (Purple)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Trial%20Accelerator%20(Purple).svgTrial Accelerator (Purple)Trial Accelerator (Purple)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Heme-Malignancy.pngHeme-MalignancyHeme-Malignancyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Whole%20Exome%20WHole%20Transcriptome.pngWhole Exome WHole TranscriptomeWhole Exome WHole Transcriptomehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360TM%20(3).pngTranslational360TM (3)Translational360TM (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Data.pngDataDatahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Liquid%20Biopsy.pngLiquid BiopsyLiquid Biopsy2026-05-28https://www.concertai.com/publications/cancer-registry-data-linkage-of-electronic-health-record-data-from-asco-s-cancerlinq-evaluation-of-advantages-limitations-and-lessons-learned2026-08-18https://www.concertai.com/acthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20Video%20v2.mp4/medium.jpgACT Video v2ACT Video v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20Video%20v2.mp4174nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20-%20Study%20Design%20Optimization.pngACT - Study Design OptimizationACT - Study Design Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cara%20Social%20SQ%20v2.pngCara Social SQ v2Cara Social SQ v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20COHORT%20CREATION.pngACT COHORT CREATIONACT COHORT CREATIONhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/D01_ConcertAI-Frost-Radar-020426.pngD01_ConcertAI-Frost-Radar-020426D01_ConcertAI-Frost-Radar-020426https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Platform%20View.pngPlatform ViewPlatform Viewhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20Social%20SQ.pngACT Social SQACT Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20-%20Site%20Selection%20Optimization.pngACT - Site Selection OptimizationACT - Site Selection Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Accelerated%20Clinical%20Trials%20Banner.pngAccelerated Clinical Trials BannerAccelerated Clinical Trials Banner2026-04-21https://www.concertai.com/publications/real-world-clinical-outcomes-of-trifluridine-tipiracil-monotherapy-ftd-tpi-and-ftd-tpi-plus-bevacizumab-combination-therapy-ftd-tpi-plus-bev-in-639-black-patients-pts2026-08-18https://www.concertai.com/publications/2024/03/real-world-outcomes-of-patients-with-advanced-non-small-cell-lung-cancer-ansclc-and-autoimmune-disease-ad-receiving-immune-checkpoint-inhibitors-icis-2/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/prognostic-impact-of-second-primary-malignancies-in-multiple-myeloma-an-asco-cancerlinq-discovery-analysis-of-the-modern-era2026-08-18https://www.concertai.com/publications/artificial-intelligence-enabled-analysis-of-unstructured-ehr-data-for-identification-of-actionable-her2-low-breast-cancer-phenotypes2026-08-18https://www.concertai.com/news/casey-graves-joins-concertai-as-general-manager-clinical-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Casey%20Graves%20PR.pngCasey Graves PRCasey Graves PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-09-11https://www.concertai.com/support-old-lphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Generic%20Banner%20(Lefty).pngConcertAI Generic Banner (Lefty)ConcertAI Generic Banner (Lefty)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Social%20SQ.pngCARAai Social SQCARAai Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Clinical%20Trial%20Optimization%20Homepage%20Image%202025.pngClinical Trial Optimization Homepage Image 2025Clinical Trial Optimization Homepage Image 2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Digital%20Trial%20Solutions%20Homepage%20Image%202025.pngDigital Trial Solutions Homepage Image 2025Digital Trial Solutions Homepage Image 2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Social%20SQ.pngTeraRecon Social SQTeraRecon Social SQ2025-05-29https://www.concertai.com/publications/real-world-analysis-of-a-large-electronic-medical-record-database-of-patients-with-higher-risk-myelodysplastic-syndromes-hr-mds-treatment-profiles-clinical2026-08-18https://www.concertai.com/supporthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Generic%20Banner%20(Lefty).pngConcertAI Generic Banner (Lefty)ConcertAI Generic Banner (Lefty)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Social%20SQ%20(1).pngConcertAI Social SQ (1)ConcertAI Social SQ (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Intro%20Splash%20Original%202.gifConcertAI Intro Splash Original 2ConcertAI Intro Splash Original 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Imaging%20Solutions%20Social%20SQ%20(1).pngTeraRecon Imaging Solutions Social SQ (1)TeraRecon Imaging Solutions Social SQ (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CLQ%20Social%20SQ.pngCLQ Social SQCLQ Social SQ2025-07-21https://www.concertai.com/news/asco-2024-study-uses-concertai-oncology-dataset-to-find-earlier-treatment-with-olaparib-monotherapy-may-improve-duration-of-therapy-and-overall-survivalhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20PR%20Poster%20-%20Olaparib%20(1).pngASCO PR Poster - Olaparib (1)ASCO PR Poster - Olaparib (1)2024-05-30https://www.concertai.com/publications/genomic-landscape-of-patients-with-non-small-cell-lung-cancer-nsclc2026-08-18https://www.concertai.com/concertai-2022-ispor-poster/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20ISPOR%202022%20JPG.jpgConcertAI ISPOR 2022 JPGConcertAI ISPOR 2022 JPGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/publications/impact-of-ibrutinib-dose-reduction-on-duration-of-therapy-in-patients-with-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-08-18https://www.concertai.com/publications/2024/03/performance-of-time-to-discontinuation-and-time-to-next-treatment-as-proxy-measures-compared-to-direct-observation-of-progression-free-survival/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/real-world-treatment-patterns-of-adjuvant-endocrine-therapy-and-ovarian-suppression-in-premenopausal-hr-plus-her2-plus-breast-cancer2026-08-18https://www.concertai.com/publications/patterns-of-concurrent-chemotherapy-selection-in-us-patients-undergoing-trimodality-therapy-for-muscle-invasive-bladder-cancer2026-08-18https://www.concertai.com/publications/real-world-pitfalls-of-analyzing-real-world-data-a-cautionary-note-and-path-forward2026-08-18https://www.concertai.com/publications/patient-profiles-treatment-patterns-and-outcomes-among-persistent-recurrent-or-metastatic-cervical-cancer-patients-under-routine-care-in-the-united-states2026-08-18https://www.concertai.com/publications/racial-disparities-in-newly-diagnosed-hematological-malignancies-in-the-united-states-during-the-covid-19-pandemic-january-2020-to-march-20212026-08-18https://www.concertai.com/news/ey-us-unveils-jeff-elton-of-concertai-as-an-entrepreneur-of-the-year-2025-new-england-award-finalisthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jeff-Elton-ConcertAI%20(1).jpgJeff-Elton-ConcertAI (1)Jeff-Elton-ConcertAI (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-04-30https://www.concertai.com/publications/national-perspectives-on-artificial-intelligence-use-in-cancer-care-confidence-adoption-and-barriers2026-08-18https://www.concertai.com/publications/real-world-baseline-treatment-patterns-and-overall-survival-rwos-in-patients-pts-with-metastatic-castration-resistant-prostate-cancer-mcrpc-treated-with-olaparib-in-the2026-08-18https://www.concertai.com/publications/real-world-patient-profiles-treatment-patterns-and-outcomes-among-recurrent-persistent-and-metastatic-cervical-cancer-patients2026-08-18https://www.concertai.com/about-ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Romesh%20Vid%20v2.mp4/medium.jpgRomesh Vid v2Romesh Vid v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Romesh%20Vid%20v2.mp4151nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Eron%20Vid%20v2.mp4/medium.jpgEron Vid v2Eron Vid v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Eron%20Vid%20v2.mp499nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jeff%20Vid%20v2.mp4/medium.jpgJeff Vid v2Jeff Vid v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jeff%20Vid%20v2.mp4162nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Shawn%20W%20Bates%20(1).pngShawn W Bates (1)Shawn W Bates (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Richard-Yates-Web-2.pngRichard-Yates-Web-2Richard-Yates-Web-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jordin%20Green.pngJordin GreenJordin Greenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(30).pngUntitled design (30)Untitled design (30)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Michael%20Myshrall-whitebkgd%20500x500.pngMichael Myshrall-whitebkgd 500x500Michael Myshrall-whitebkgd 500x500https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/mission%20background.pngmission backgroundmission backgroundhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Casey%20Graves-whitebkgd%20500x500.pngCasey Graves-whitebkgd 500x500Casey Graves-whitebkgd 500x500https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Missy%20Jerome%20trans%20background.pngMissy Jerome trans backgroundMissy Jerome trans backgroundhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(31).pngUntitled design (31)Untitled design (31)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(99).pngUntitled design (99)Untitled design (99)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Dhiraj%20Carumbaya-3.pngDhiraj Carumbaya-3Dhiraj Carumbaya-3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Eron%20Kelly%20Headshot%20-%20no%20background%20(2).pngEron Kelly Headshot - no background (2)Eron Kelly Headshot - no background (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(1)-1%20(1).webpUntitled design (1)-1 (1)Untitled design (1)-1 (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Images/Headshots/Jeff_Elton.jpegJeff_EltonJeff_Eltonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Claudio-DAmbrosio-01-scaled.jpgClaudio-DAmbrosio-01-scaledClaudio-DAmbrosio-01-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Pyeush-G-New-Web-Portrait-scaled.jpgPyeush-G-New-Web-Portrait-scaledPyeush-G-New-Web-Portrait-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jennifer%20Rider%20-%202%20-%20transp.pngJennifer Rider - 2 - transpJennifer Rider - 2 - transphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Romesh%20Portrait.pngRomesh PortraitRomesh Portrait2026-05-28https://www.concertai.com/publications/characteristics-of-real-world-natalee-and-monarche-eligible-populations-with-hr-plus-her2-early-breast-cancer-a-united-states-electronic-health-records-database-analysis2026-08-18https://www.concertai.com/publications/real-world-evidence-comparison-of-first-line-1l-immune-oncology-io-tyrosine-kinase-inhibitor-tki-vs-io-io-combination-therapy-in-renal-cell-carcinoma-rcc2026-08-18https://www.concertai.com/events/j-p-morgan-healthcare-conference/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-12024-03-26https://www.concertai.com/news/asco-2024-study-demonstrates-that-ai-based-clinical-trial-screening-is-more-than-3x-faster-than-traditional-methodshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2024%20CAI%20ASCO%20-%20Rectangle-%20Study%203x%20faster.png2024 CAI ASCO - Rectangle- Study 3x faster2024 CAI ASCO - Rectangle- Study 3x faster2024-05-29https://www.concertai.com/resourceshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWDE-ECA-for-Regulatory.pngRWDE-ECA-for-RegulatoryRWDE-ECA-for-Regulatoryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/DTS-Factsheet-Providers-NEW-COVER.jpgDTS-Factsheet-Providers-NEW-COVERDTS-Factsheet-Providers-NEW-COVERhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/CTO-Resource-Cover-1.pngCTO-Resource-Cover-1CTO-Resource-Cover-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360-FS-Cover-1.pngPatient360-FS-Cover-1Patient360-FS-Cover-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/PP-WhitePaper_Optimizing_Your_Patient_Analytics-1.pngPP-WhitePaper_Optimizing_Your_Patient_Analytics-1PP-WhitePaper_Optimizing_Your_Patient_Analytics-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/DTS-Factsheet-Sponsors-NEW-COVER.jpgDTS-Factsheet-Sponsors-NEW-COVERDTS-Factsheet-Sponsors-NEW-COVERhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Neo-Fact-Sheet-Cover.pngNeo-Fact-Sheet-CoverNeo-Fact-Sheet-Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWDE-Dynamic-RWE-Registry-FS-Cover.pngRWDE-Dynamic-RWE-Registry-FS-CoverRWDE-Dynamic-RWE-Registry-FS-Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/STAR-Fact-Sheet.jpgSTAR-Fact-SheetSTAR-Fact-Sheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening-Factsheet-Sponsors-NEW-COVER.jpgeScreening-Factsheet-Sponsors-NEW-COVEReScreening-Factsheet-Sponsors-NEW-COVERhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/photo-1550353127-b0da3aeaa0ca_cropped-for-hero_1.pngphoto-1550353127-b0da3aeaa0ca_cropped-for-hero_1photo-1550353127-b0da3aeaa0ca_cropped-for-hero_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/casestudy-Predictive-Patient_Transforming-Patient-Adherence_thumbnail-for-content-page-1.pngcasestudy-Predictive-Patient_Transforming-Patient-Adherence_thumbnail-for-content-page-1casestudy-Predictive-Patient_Transforming-Patient-Adherence_thumbnail-for-content-page-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RWD360%20Cover%20(NEW%202).jpgRWD360 Cover (NEW 2)RWD360 Cover (NEW 2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/PP-Case-Study_Predicting-Prescribers-with-Patients-Most-Likely-to-Fill_Thumbnail-for-Content-Page.pngPP-Case-Study_Predicting-Prescribers-with-Patients-Most-Likely-to-Fill_Thumbnail-for-Content-PagePP-Case-Study_Predicting-Prescribers-with-Patients-Most-Likely-to-Fill_Thumbnail-for-Content-Pagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening-Factsheet-Providers-NEW-COVER.jpgeScreening-Factsheet-Providers-NEW-COVEReScreening-Factsheet-Providers-NEW-COVERhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Caris-FS-Cover.pngCaris-FS-CoverCaris-FS-Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Data-Aggregation-Factsheet-UPDATED-Cover-Cropped.jpgData-Aggregation-Factsheet-UPDATED-Cover-CroppedData-Aggregation-Factsheet-UPDATED-Cover-Croppedhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/PathAI-FS-Cover.pngPathAI-FS-CoverPathAI-FS-Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/PP-Fact-Sheet-Thumbnail-for-Content-Page.pngPP-Fact-Sheet-Thumbnail-for-Content-PagePP-Fact-Sheet-Thumbnail-for-Content-Page2024-04-03https://www.concertai.com/precision-suitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Speed%202.svgSpeed 2Speed 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Clarity.svgClarityClarityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Social%20SQ.pngPrecision360 Social SQPrecision360 Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials.pngPrecision TrialsPrecision Trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Suite%20Cover.pngPrecision Suite CoverPrecision Suite Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Social%20SQ%20(2).pngPrecision360 Social SQ (2)Precision360 Social SQ (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Wow%20Screen.pngWow ScreenWow Screenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360TM%20(2).pngTranslational360TM (2)Translational360TM (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Suite%20Banner.pngPrecision Suite BannerPrecision Suite Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Continuity-1.svgContinuity-1Continuity-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%202%20AI.svgPrecision 2 AIPrecision 2 AIhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SoC%20to%20RW%20Treatment%20Progression%20Comparison.pngSoC to RW Treatment Progression ComparisonSoC to RW Treatment Progression Comparisonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Social%20SQ%20(1).pngPrecision360 Social SQ (1)Precision360 Social SQ (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20Screen.pngPrecision Trials ScreenPrecision Trials Screen2026-04-21https://www.concertai.com/publications/2024/03/trends-in-immunotherapy-use-in-patients-with-advanced-non-small-cell-lung-cancer-ansclc-patients-analysis-of-real-world-data/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/blog/2023/06/asco-2023-reflectionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ASCO-Reflections-Banner-Final-1024x256-1.pngASCO-Reflections-Banner-Final-1024x256-1ASCO-Reflections-Banner-Final-1024x256-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ASCO-2023-Reflections-Graphic-1.pngASCO-2023-Reflections-Graphic-1ASCO-2023-Reflections-Graphic-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-17https://www.concertai.com/news/concertai-receives-2026-silver-stevie-award-for-technology-excellencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SATE26_Silver_Winner.pngSATE26_Silver_WinnerSATE26_Silver_Winnerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-07-29https://www.concertai.com/publications/disparities-in-genetic-testing-patterns-and-positivity-among-patients-with-breast-cancer-in-the-cancerlinq-real-world-oncology-database2026-08-18https://www.concertai.com/publications/treatment-patterns-and-outcomes-associated-with-sequential-and-non-sequential-use-of-cdk4-and-6-inhibitors-in-patients-with-hr-plus-her2-mbc-in-the-real-world2026-08-18https://www.concertai.com/publications/assessment-of-electronic-health-record-ehr-based-machine-learning-ml-in-predicting-risk-of-brain-metastasis-among-patients-with-early-stage-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/dynamic-custom-rwd-registry-factsheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic-RWE-Registry-Fan-768x768.pngDynamic-RWE-Registry-Fan-768x768Dynamic-RWE-Registry-Fan-768x7682024-04-01https://www.concertai.com/publications/harness-the-power-of-real-world-data-for-oncology-target-and-biomarker-research-a-case-study-by-applying-clinic-genomics-data-for-2-659-lung-cancer-patients-and-beyond2026-08-18https://www.concertai.com/publications/2024/03/study-of-relapse-or-refractory-r-r-flt3-mutated-acute-myeloid-leukemia-aml-using-electronic-medical-records-emr-first-analysis-fromhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/natural-language-processing-optimized-case-selection-for-real-world-evidence-studies2026-08-18https://www.concertai.com/publications/biomarker-testing-and-treatment-patterns-in-us-patients-pts-with-advanced-metastatic-nonsmall-cell-lung-cancer-nsclc-harboring-met-amplification2026-08-18https://www.concertai.com/publications/effect-of-ifng-expression-levels-on-real-world-survival-outcomes-in-patients-with-metastatic-non-small-cell-lung-cancer-receiving-immunotherapy2026-08-18https://www.concertai.com/publications/luminate-102-a-real-world-study-on-biomarker-testing-rates-among-patients-with-non-small-cell-lung-cancer-nsclc-across-lines-of-therapy2026-08-18https://www.concertai.com/publications/comparison-of-outcomes-for-patients-pts-with-r-r-chronic-lymphocytic-leukemia-cll-small-lymphocytic-lymphoma-sll-previously-treated-with-bruton-tyrosine-kinase2026-08-18https://www.concertai.com/rxlinqhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Efficiency.svgEfficiencyEfficiencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RxLinQ%20Banner.pngRxLinQ BannerRxLinQ Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RxLinQ%20Suite%20Social%20SQ.pngRxLinQ Suite Social SQRxLinQ Suite Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Built%20for.svgBuilt forBuilt forhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Admin%20time.svgAdmin timeAdmin timehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RxLinQ%20Cover-1.pngRxLinQ Cover-1RxLinQ Cover-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Improved%20Treatment.svgImproved TreatmentImproved Treatment2025-05-29https://www.concertai.com/publications/seeking-american-society-of-clinical-oncology-qualityoncology-practice-initiative-asco-qopi-certification-in-anorthern-new-england-rural-health-system-and-cancer-care2026-08-18https://www.concertai.com/publications/real-world-rw-frontline-1l-treatments-txs-in-patients-pts-with-advanced-non-small-cell-lung-cancer-nsclc-harboring-epidermal-growth-factor-receptor-efgr-exon-202026-08-18https://www.concertai.com/publications/a-multi-agent-system-for-automated-identification-of-competitive-clinical-trials-in-colorectal-cancer2026-08-18https://www.concertai.com/news/concertai-launches-accelerated-clinical-trials-leveraging-agentic-ai-to-streamline-trial-timelineshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20ConcertAI%20Launches%20Accelerated%20Clinical%20Trials%2c%20Leveraging%20Agentic%20AI%20to%20Streamline%20Trial%20Timelines.pngConcertAI Press Release ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Streamline Trial TimelinesConcertAI Press Release ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Streamline Trial Timelines2026-02-02https://www.concertai.com/publications/machine-learning-model-to-forecast-patient-availability-for-oncology-clinical-trials2026-08-18https://www.concertai.com/publications/augmenting-synthetic-control-arms-using-bayesian-borrowing-a-case-study-in-first-line-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/mutations-in-the-bruton-tyrosine-kinase-btk-gene-in-patients-with-chronic-lymphocytic-leukemia-cll-receiving-btk-inhibitors-btkis2026-08-18https://www.concertai.com/precision-suite-oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Suite%20Banner.pngPrecision Suite BannerPrecision Suite Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Speed%202.svgSpeed 2Speed 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SoC%20to%20RW%20Treatment%20Progression%20Comparison.pngSoC to RW Treatment Progression ComparisonSoC to RW Treatment Progression Comparisonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360TM%20(2).pngTranslational360TM (2)Translational360TM (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20Art.pngPrecision Trials ArtPrecision Trials Arthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20GTM%20Art.pngPrecision GTM ArtPrecision GTM Arthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Suite%20Cover.pngPrecision Suite CoverPrecision Suite Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Clarity.svgClarityClarityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%202%20AI.svgPrecision 2 AIPrecision 2 AIhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Wow%20Screen.pngWow ScreenWow Screenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20Screen.pngPrecision Trials ScreenPrecision Trials Screenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20Art.pngPrecision Explorer ArtPrecision Explorer Arthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials.pngPrecision TrialsPrecision Trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Continuity-1.svgContinuity-1Continuity-12025-05-29https://www.concertai.com/publications/real-world-evaluation-of-outcomes-in-relapsed-refractory-multiple-myeloma-patients-that-are-triple-class-exposed-after-receiving-2-or-more-prior-lines-of-therapy2026-08-18https://www.concertai.com/fact-sheet_data-aggregationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Precision-Patient-Analytics-Fan.pngPrecision-Patient-Analytics-FanPrecision-Patient-Analytics-Fanhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Data-Aggregation-Factsheet-UPDATED-Cover-Cropped.jpgData-Aggregation-Factsheet-UPDATED-Cover-CroppedData-Aggregation-Factsheet-UPDATED-Cover-Cropped2024-05-01https://www.concertai.com/download-landing-page/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Hero%20Erace.jpgHero EraceHero Eracehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/blog/2023/08/a-call-to-action-addressing-cancer-drug-shortageshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/A-Call-to-Action-Addressing-Cancer-Drug-Shortages-Image-1.pngA-Call-to-Action-Addressing-Cancer-Drug-Shortages-Image-1A-Call-to-Action-Addressing-Cancer-Drug-Shortages-Image-12024-03-17https://www.concertai.com/real-world-evidencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop01-04-RealWorldEvidence.mp4/medium.jpgCAI-BGLoop01-04-RealWorldEvidenceCAI-BGLoop01-04-RealWorldEvidencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop01-04-RealWorldEvidence.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CancerLinQ%20Suite-2.mp4/medium.jpgCancerLinQ Suite-2CancerLinQ Suite-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CancerLinQ%20Suite-2.mp4121nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360%20v1.pngTranslational360 v1Translational360 v1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20V1-2.pngPrecision Explorer V1-2Precision Explorer V1-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient360%20v1.pngPatient360 v1Patient360 v1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20V1-3.pngPrecision Explorer V1-3Precision Explorer V1-3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Image%201.pngPrecision360 Image 1Precision360 Image 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Scientific%20Services%20V1.pngScientific Services V1Scientific Services V1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NeoGenomics.svg.pngNeoGenomics.svgNeoGenomics.svghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Foundation%20Medicine%20Logo.svgFoundation Medicine LogoFoundation Medicine Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Guardant%20Health.svgGuardant HealthGuardant Healthhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CarisLS_Color_Primary_Logo.webpCarisLS_Color_Primary_LogoCarisLS_Color_Primary_Logo2026-05-29https://www.concertai.com/publications/associations-between-biomarker-testing-and-characteristics-of-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc-an-analysis-of-cancerlinq-discovery-clqd-data2026-08-18https://www.concertai.com/publications/secondary-primary-malignancies-spms-in-adolescent-and-young-adults-ayas-with-multiple-myeloma-mm-an-asco-cancerlinq-analysis2026-08-18https://www.concertai.com/job-application/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/publications/developing-a-digital-twin-framework-for-colorectal-cancer-outcome-prediction-and-robust-clinical-trial-simulation2026-08-18https://www.concertai.com/blog/lightning-strikes-why-your-company-needs-an-ai-action-planhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lightning%20Strikes%20-%20AI%20Action%20Plan.pngConcertAI Blog - Lightning Strikes - AI Action PlanConcertAI Blog - Lightning Strikes - AI Action Planhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-07-28https://www.concertai.com/publications/real-world-adjuvant-nivolumab-utilization-in-surgically-treated-muscle-invasive-bladder-cancer-patients-within-u-s-community-oncology-practice2026-08-18https://www.concertai.com/publications/patients-with-advanced-non-small-cell-lung-cancer-harboring-met-alterations-a-descriptive-cohort-study2026-08-18https://www.concertai.com/news/concertai-and-foundation-medicine-integrate-genomic-and-clinical-data-to-transform-translational-research-and-efficient-drug-developmenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20and%20Foundation%20Medicine%20Integrate%20Genomic%20and%20Clinical%20Data%20to%20Transform%20Translational%20Research%20and%20Efficient%20Drug%20Development.pngConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug DevelopmentConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Developmenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-01-12https://www.concertai.com/privacy-policyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-06-18https://www.concertai.com/publications/identifying-cancer-germline-variants-associated-with-patient-prognosis-and-response-by-applying-clinico-genomics-data2026-08-18https://www.concertai.com/concertai-at-aacr-2023https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/AACR-2023-SVG-Overlay.svgAACR-2023-SVG-OverlayAACR-2023-SVG-Overlayhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/4.png44https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us-1.svgMeet-With-Us-1Meet-With-Us-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/3%20(1).png3 (1)3 (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/AACR-2023-eSig.pngAACR-2023-eSigAACR-2023-eSighttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-AACR-2023-Abstracts.pngConcertAI-AACR-2023-AbstractsConcertAI-AACR-2023-Abstractshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/AACR-2023-Banner-BG-3.pngAACR-2023-Banner-BG-3AACR-2023-Banner-BG-32024-04-02https://www.concertai.com/publications/real-world-treatment-and-outcomes-for-egfr-wt-advanced-metastatic-non-squamous-non-small-cell-lung-cancer-pooled-analysis-from-project-luminate-1012026-08-18https://www.concertai.com/publications/leveraging-nsclc-foundation-models-to-predict-biomarker-testing-pattern2026-08-18https://www.concertai.com/terarecon-ai-frameworkhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20AI%20Framework.pngTeraRecon AI FrameworkTeraRecon AI Frameworkhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-07-27https://www.concertai.com/publications/evaluation-of-treatment-strategies-for-patients-with-stage-iiia-non-small-cell-lung-cancer-in-the-immunotherapy-era2026-08-18https://www.concertai.com/publications/real-world-clinical-outcomes-among-metastatic-colorectal-cancer-mcrc-patients-with-liver-metastases-who-received-trifluridine-tipiracil-ftd-tpi-or-ftd-tpi-plus2026-08-18https://www.concertai.com/publications/reaching-beyond-maximum-grade-progress-and-future-directions-for-modernising-the-assessment-and-reporting-of-adverse-events-in-haematological-malignancies2026-08-18https://www.concertai.com/publications/real-world-clinical-outcomes-of-patients-with-brca-mutated-human-epidermal-growth-factor-receptor-2-her2-negative-metastatic-breast-cancer-a-cancerlinq-study2026-08-18https://www.concertai.com/publications/development-of-natural-language-processing-nlp-models-for-extracting-key-features-from-unstructured-notes-to-create-real-world-data-rwd-assets-for-clinical-research-at2026-08-18https://www.concertai.com/news/concertai-expands-cancerlinq-suite-with-ai-driven-trial-matching-and-contextualized-patient-insights-to-support-oncologists-at-the-point-of-carehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PR-Expands%20CancerLinQ%20Suite%20(2).pngPR-Expands CancerLinQ Suite (2)PR-Expands CancerLinQ Suite (2)2026-05-28https://www.concertai.com/news/concertai-appoints-michael-myshrall-as-chief-financial-officerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Michael%20Myshrall%20PR.pngMichael Myshrall PRMichael Myshrall PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-08-18https://www.concertai.com/concertai-at-aacr-special-conferencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Caris-Factsheet-Fan.pngCaris-Factsheet-FanCaris-Factsheet-Fanhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening-Banner-BG-2-1.pngeScreening-Banner-BG-2-1eScreening-Banner-BG-2-12024-04-03https://www.concertai.com/publications/real-world-patient-characteristics-and-treatment-patterns-in-us-patients-with-advanced-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/systemic-anticancer-therapy-in-patients-with-de-novo-metastatic-pancreatic-adenocarcinoma-a-real-world-analysis2026-08-18https://www.concertai.com/publications/cohort-optimizer-a-software-solution-that-uses-real-world-data-and-ai-to-optimize-criteria-of-oncology-trials2026-08-18https://www.concertai.com/starhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%201.pngSTAR 1STAR 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%20Banner.pngSTAR BannerSTAR Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%20Social%20SQ.pngSTAR Social SQSTAR Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%203.pngSTAR 3STAR 3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2029.svgAsset 29Asset 29https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2023.svgAsset 23Asset 23https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%202.pngSTAR 2STAR 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%204.pngSTAR 4STAR 4https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/STAR%20Cover.pngSTAR CoverSTAR Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2027.svgAsset 27Asset 27https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2028.svgAsset 28Asset 282025-09-25https://www.concertai.com/publications/real-world-effectiveness-of-met-inhibitors-versus-immunotherapy-plus-minus-chemotherapy-in-1l-for-patients-with-met-exon-14-skipping-mutations-in-non-small-cell-lung2026-08-18https://www.concertai.com/events/asembias-axs24-summit/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-12024-03-26https://www.concertai.com/advanced-visualizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Terarecon%20AV.mp4/medium.jpgTerarecon AVTerarecon AVhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Terarecon%20AV.mp4108nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-02-AdvancedVisualization.mp4/medium.jpgCAI-BGLoop-02-AdvancedVisualizationCAI-BGLoop-02-AdvancedVisualizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-02-AdvancedVisualization.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Advanced%20Workflows%20(NEW).pngAdvanced Workflows (NEW)Advanced Workflows (NEW)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/evar-sten.pngevar-stenevar-stenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CT%20Neuro%20Perfusion%202.pngCT Neuro Perfusion 2CT Neuro Perfusion 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20AV%20(2).pngTeraRecon AV (2)TeraRecon AV (2)2026-06-18https://www.concertai.com/publications/real-world-use-patterns-and-clinical-outcomes-for-myelodysplastic-syndrome-patients-initiating-oral-decitabine-and-cedazuridine-or-intravenous-subcutaneous2026-08-18https://www.concertai.com/publications/-real-world-management-and-outcomes-for-newly-diagnosed-aml-patients-initiating-venetoclax-and-hypomethylating-agents-in-us-community-practice2026-08-18https://www.concertai.com/case-study_predicting-prescribers-with-patients-most-likely-to-fillhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/PP-Case-Study_Predicting-Prescribers-with-Patients-Most-Likely-to-Fill_Thumbnail-for-Content-Page-1024x529.pngPP-Case-Study_Predicting-Prescribers-with-Patients-Most-Likely-to-Fill_Thumbnail-for-Content-Page-1024x529PP-Case-Study_Predicting-Prescribers-with-Patients-Most-Likely-to-Fill_Thumbnail-for-Content-Page-1024x529https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/publications/goserelin-3-month-depot-shows-non-inferiority-to-the-monthly-formulation-in-u-s-patients-with-premenopausal-breast-cancer-a-real-world-evidence-study2026-08-18https://www.concertai.com/news/2024/01/jennifer-rider-appointed-concertai-head-of-real-world-evidence-serviceshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Jennifer-Rider-PR.pngJennifer-Rider-PRJennifer-Rider-PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-04-01https://www.concertai.com/publications/developing-an-ehr-based-multifeature-machine-learning-model-to-identify-lung-cancer-subtype2026-08-18https://www.concertai.com/publications/real-world-egfr-testing-and-adjuvant-treatment-patterns-among-patients-with-resected-early-stage-non-small-cell-lung-cancer-nsclc-in-the-united-states2026-08-18https://www.concertai.com/request-a-demohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Generic%20Banner%20(Lefty).pngConcertAI Generic Banner (Lefty)ConcertAI Generic Banner (Lefty)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2025-05-30https://www.concertai.com/publications/pediatric-cancer-in-the-united-states-a-comparison-of-three-data-sources2026-08-18https://www.concertai.com/publications/real-world-rebiopsy-and-biomarker-retesting-rates-among-patients-with-non-small-cell-lung-cancer-across-patient-demographics-in-the-united-states2026-08-18https://www.concertai.com/news/nick-jones-appointed-svp-and-gm-commercial-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Nick%20Jones%20PR.pngNick Jones PRNick Jones PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-06-06https://www.concertai.com/news/featured-in-wsj-pro-why-timing-matters-in-clinical-trial-recruitmenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-07-29https://www.concertai.com/publications/identifying-genetic-factors-for-resistance-and-response-to-immune-checkpoint-inhibitors-icis-in-advanced-non-small-cell-lung-cancer-ansclc-patients-using-real-world-data2026-08-18https://www.concertai.com/dts-for-providers-factsheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DTS%20Providers%20Cover.jpgDTS Providers CoverDTS Providers Cover2024-05-22https://www.concertai.com/publications/pathway-level-molecular-evolution-and-composite-molecular-genomic-risk-following-lu-177-psma-617-in-metastatic-castration-resistant-prostate-cancer2026-08-18https://www.concertai.com/concertai-esmo2023/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us.svgMeet-With-UsMeet-With-Ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ESMO%20Madrid%20text.svgESMO Madrid textESMO Madrid texthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Generating%20Multi-modal%20Real-world%20Data.svgGenerating Multi-modal Real-world DataGenerating Multi-modal Real-world Datahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ESMO%20Madrid.pngESMO MadridESMO Madridhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ESMO%202023%20Employee%20eSig.pngESMO 2023 Employee eSigESMO 2023 Employee eSighttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Advancing%20Equity%20&%20Trial%20Diversity.svgAdvancing Equity & Trial DiversityAdvancing Equity & Trial Diversityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Accelerating%20Study%20Design%20&%20Execution.svgAccelerating Study Design & ExecutionAccelerating Study Design & Executionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)2024-12-17https://www.concertai.com/asco-2025-publications-concertaihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Purple.jpgPublications-PurplePublications-Purplehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-9560-e.pngCAI ASCO Publications-9560-eCAI ASCO Publications-9560-ehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-1566-e.pngCAI ASCO Publications-1566-eCAI ASCO Publications-1566-ehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Pool-Blue.jpgPublications-Pool-BluePublications-Pool-Bluehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Ocean-Blu-2048x1152.jpgPublications-Ocean-Blu-2048x1152Publications-Ocean-Blu-2048x1152https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-v2-10562-e.pngCAI ASCO Publications-v2-10562-eCAI ASCO Publications-v2-10562-ehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Blurple.jpgPublications-BlurplePublications-Blurplehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-5591-e.pngCAI ASCO Publications-5591-eCAI ASCO Publications-5591-ehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PUBLICATIONS%20Banner.pngPUBLICATIONS BannerPUBLICATIONS Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-1553-CLQ-e.pngCAI ASCO Publications-1553-CLQ-eCAI ASCO Publications-1553-CLQ-e2025-05-23https://www.concertai.com/publications/real-world-trends-in-the-evolving-use-of-first-line-therapy-in-metastatic-castration-sensitive-prostate-cancer-patients-mcspc-in-the-united-states2026-08-18https://www.concertai.com/events/scope-2024/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-12024-03-26https://www.concertai.com/blog/2024/03/the-concertai-podcast-the-future-of-drug-development-ai-rwd-and-regulatory-insightshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Artboard%201%20copy%2016@2x.pngArtboard 1 copy 16@2xArtboard 1 copy 16@2xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-05-29https://www.concertai.com/asco-2021-research_assessment-of-differences-among-black-and-white-patients-with-covid/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Sudip-New-Cover-scaled.jpgSudip-New-Cover-scaledSudip-New-Cover-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/icon-play.svgicon-playicon-play2024-04-01https://www.concertai.com/annual-reportshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Trujay%20Migration%20Hidden%20Files/JP%20Morgan%20PR%20Low%20Res%20v2.pngJP Morgan PR Low Res v2JP Morgan PR Low Res v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Generic%20Banner%20(Lefty).pngConcertAI Generic Banner (Lefty)ConcertAI Generic Banner (Lefty)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Social%20SQ.pngSpecialty Data Social SQSpecialty Data Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2025-05-29https://www.concertai.com/news/concertai-to-advance-translational-and-clinical-development-solutions-in-collaboration-with-nvidiahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NVIDIA%20Collaboration%20PR.pngNVIDIA Collaboration PRNVIDIA Collaboration PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-06-02https://www.concertai.com/publications/evaluation-of-cost-effectiveness-of-adjuvant-osimertinib-in-patients-with-resected-egfr-mutation-positive-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/shifting-treatment-patterns-in-chromophobe-renal-cell-carcinoma-a-u-s-real-world-data-analysis2026-08-18https://www.concertai.com/publications/egfr-mutation-testing-treatment-and-survival-in-stage-i-iii-non-small-cell-lung-cancer-cancerlinq-discovery-database-retrospective-analysis2026-08-18https://www.concertai.com/publications/uptake-and-efficacy-of-immuno-oncology-combinations-in-metastatic-renal-cell-carcinoma-in-the-united-states-evidence-from-the-asco-cancerlinq-discovery-database2026-08-18https://www.concertai.com/publications/multiple-myeloma-in-adolescent-and-young-adults-an-asco-cancerlinq-and-seer-analysis2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-outcomes-of-daratumumab-retreatment-in-multiple-myeloma-in-the-united-states2026-08-18https://www.concertai.com/publications/treatment-effectiveness-in-a-rare-oncology-indication-lessons-from-an-external-control-cohort-study2026-08-18https://www.concertai.com/news/cancerlinq-receives-asco-certified-rqs-recognitionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20ConcertAI%20ASCO%20Certified.pngConcertAI Press Release ConcertAI ASCO CertifiedConcertAI Press Release ConcertAI ASCO Certifiedhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-08-27https://www.concertai.com/publications/early-stage-unfavorable-hodgkin-lymphoma-patient-characteristics-in-real-world-oncology-data-from-the-united-states2026-08-18https://www.concertai.com/publications/evaluation-of-real-world-tumor-response-derived-from-electronic-health-record-data-sources-a-feasibility-analysis-in-mnsclc-patients-treated-with-chemotherapy2026-08-18https://www.concertai.com/events/biotechx-europe-2024/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/publications/exploration-of-real-world-outcomes-in-patients-with-previously-treated-hr-plus-her2-and-triple-negative-metastatic-breast-cancer2026-08-18https://www.concertai.com/blog/from-orchestration-to-discovery-concertai-nvidia-and-what-comes-next-with-bionemohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-06-24https://www.concertai.com/publications/disease-free-survival-dfs-as-a-predictor-of-overall-survival-in-completely-reseacted-early-stage-non-small-cell-lung-cancer-nsclc2026-08-18https://www.concertai.com/blog/2023/05/accelerating-evidence-and-biomedical-innovations-with-multi-modal-data-and-advanced-aihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-30@2x-1024x256-1.pngArtboard-1-copy-30@2x-1024x256-1Artboard-1-copy-30@2x-1024x256-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-16_1@2x2-1.pngArtboard-1-copy-16_1@2x2-1Artboard-1-copy-16_1@2x2-12024-03-17https://www.concertai.com/clinical-trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Clinical%20Trials%20Platform-1.mp4/medium.jpgCAI Clinical Trials Platform-1CAI Clinical Trials Platform-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Clinical%20Trials%20Platform-1.mp4162nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-06-Clinical%20Trials.mp4/medium.jpgCAI-BGLoop-06-Clinical TrialsCAI-BGLoop-06-Clinical Trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-06-Clinical%20Trials.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Microsoft%20Teams%20Background%20v8.pngMicrosoft Teams Background v8Microsoft Teams Background v8https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Astellas%20White.svgAstellas WhiteAstellas Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_CancerLinQ_3.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_CancerLinQ_3CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_CancerLinQ_3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT.pngACTACThttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amgen%20Logo%20White.svgAmgen Logo WhiteAmgen Logo Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Regeneron.svgRegeneronRegeneronhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/abbvie.svgabbvieabbviehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Clinical%20Trials%20Cover-2.pngConcertAI Clinical Trials Cover-2ConcertAI Clinical Trials Cover-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AstraZeneca.svgAstraZenecaAstraZenecahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Merck%20(White).svgMerck (White)Merck (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Social%20SQ.pngCARAai Social SQCARAai Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Lilly%20Logo%20(White).svgLilly Logo (White)Lilly Logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Image%201.pngPrecision360 Image 1Precision360 Image 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Otsuka_Holdings_logo%20(White).svgOtsuka_Holdings_logo (White)Otsuka_Holdings_logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-07-09https://www.concertai.com/publications/a-combined-machine-learning-and-natural-language-processing-approach-to-determine-metastatic-date-through-integrated-temporal-modeling2026-08-18https://www.concertai.com/publications/2024/03/performance-of-time-to-discontinuation-and-time-to-next-treatment-as-proxy-measures-of-progression-free-survival-overall-and-by-treatment-group/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/terarecon-avhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Terarecon%20AV.mp4/medium.jpgTerarecon AVTerarecon AVhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Terarecon%20AV.mp4108nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6-1.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6-1CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20AV%20(1).pngTeraRecon AV (1)TeraRecon AV (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-07-27https://www.concertai.com/contact-ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-12026-06-08https://www.concertai.com/blog/from-biopsy-to-breakthrough-real-world-genomics-in-early-stage-oncology-trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM.pngConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM2025-05-29https://www.concertai.com/publications/augmentation-of-real-world-mortality-data-in-the-electronic-medical-record-assessing-the-impact-on-overall-survival-estimates-in-multiple-myeloma2026-08-18https://www.concertai.com/publications/disparities-in-timely-treatment-among-lung-cancer-patients2026-08-18https://www.concertai.com/news/concertai-introduces-terarecon-av-advancing-ai-powered-medical-imaging-with-new-structural-heart-and-saas-capabilitieshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20TeraRecon%20AV%20(1).pngConcertAI Press Release TeraRecon AV (1)ConcertAI Press Release TeraRecon AV (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-11-20https://www.concertai.com/publications/contemporary-real-world-patterns-of-precision-medicine-in-metastatic-nsclc2026-08-18https://www.concertai.com/news/dewpoint-therapeutics-and-concertai-announce-the-first-phase-of-their-translational-oncology-partnershiphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2024%20CAI%20ASCO%20-%20Rectangle%20(7).png2024 CAI ASCO - Rectangle (7)2024 CAI ASCO - Rectangle (7)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-03-26https://www.concertai.com/publications/dynamic-machine-learning-model-to-forecast-patient-availability-for-clinical-trials2026-08-18https://www.concertai.com/publications/disparities-in-patients-with-her2-positive-breast-cancer-receiving-optimal-treatment-analysis-of-the-real-world-asco-cancerlinq-dataset2026-08-18https://www.concertai.com/publications/estimating-us-cancer-prevalence-with-community-oncology-ehr-based-datasets-via-national-benchmarks-from-seer-and-npcr2026-08-18https://www.concertai.com/publications/epidemiology-of-met-gene-mrna-expression-in-metastatic-colorectal-cancer-analyses-of-a-real-world-clinicogenomic-database2026-08-18https://www.concertai.com/news/concertai-announces-strategic-agreement-with-bayer-to-accelerate-drug-discovery-and-clinical-development-in-precision-oncologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20ConcertAI%20Announces%20Strategic%20Agreement%20with%20Bayer%20to%20Accelerate%20Drug%20Discovery%20and%20Clinical%20Development%20in%20Precision%20Oncology.pngConcertAI Press Release ConcertAI Announces Strategic Agreement with Bayer to Accelerate Drug Discovery and Clinical Development in Precision OncologyConcertAI Press Release ConcertAI Announces Strategic Agreement with Bayer to Accelerate Drug Discovery and Clinical Development in Precision Oncologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-04-30https://www.concertai.com/blog/2024/03/the-concertai-podcast-prostate-cancer-awareness-with-steve-osunsamihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Steve%20O%20Episode%20Image.pngSteve O Episode ImageSteve O Episode Image2025-03-11https://www.concertai.com/precision-explorerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer_4K.mp4/medium.jpgPrecision Explorer_4KPrecision Explorer_4Khttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer_4K.mp482nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20V1.pngPrecision Explorer V1Precision Explorer V1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Population%20Comorbidities%20Analysis.pngPopulation Comorbidities AnalysisPopulation Comorbidities Analysishttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cohort%20Build%20&%20Explore%202%20(Patient%20Population).pngCohort Build & Explore 2 (Patient Population)Cohort Build & Explore 2 (Patient Population)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Overall%20Survival%20(OS)%20Analysis.pngOverall Survival (OS) AnalysisOverall Survival (OS) Analysishttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SoC%20to%20RW%20Treatment%20Progression%20Comparison-1.pngSoC to RW Treatment Progression Comparison-1SoC to RW Treatment Progression Comparison-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_1.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_1CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_12026-05-27https://www.concertai.com/publications/predictive-modeling-for-survival-outcomes-in-surgically-resected-pancreatic-ductal-adenocarcinoma-a-comprehensive-machine-learning-approach-using-real-world-data2026-08-18https://www.concertai.com/publications/treatment-patterns-and-outcomes-in-patients-with-relapsed-refractory-multiple-myeloma-receiving-greater-than-or-equal-to-3-lines-of-therapy-a-real-world-evaluation-in2026-08-18https://www.concertai.com/news/2023/04/pathai-and-concertai-partnershiphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/PathAI-Partnership-Social-Graphic.pngPathAI-Partnership-Social-GraphicPathAI-Partnership-Social-Graphichttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-12-17https://www.concertai.com/sample-page-created-by-hubspot-migration-teamhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/newsroomhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/gptw_marketing_cert_badge_2024-scaled.pnggptw_marketing_cert_badge_2024-scaledgptw_marketing_cert_badge_2024-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_1.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_1CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CTA.pngCTACTAhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_ClinicalTrials_5.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_ClinicalTrials_5CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_ClinicalTrials_5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2021-best-in-klas-advanced-visualization%20(1).svg2021-best-in-klas-advanced-visualization (1)2021-best-in-klas-advanced-visualization (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/THR_logo_vfinal.1c3b13d6-e1652452886104.webpTHR_logo_vfinal.1c3b13d6-e1652452886104THR_logo_vfinal.1c3b13d6-e16524528861042026-05-28https://www.concertai.com/publications/biomarker-defined-outcomes-in-metastatic-clear-cell-renal-cell-carcinoma-mccrcc-receiving-first-line-1l-immune-checkpoint-inhibitor-based-therapy2026-08-18https://www.concertai.com/publications/race-differences-in-patient-reported-symptoms-and-adherence-to-adjuvant-endocrine-therapy-among-women-with-early-stage-hormone-receptor-positive-breast-cancer2026-08-18https://www.concertai.com/news/guardant-health-and-concertai-set-commercial-goals-for-cancer-therapy-data-sharing-dealhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Featured%20Article%20-%20Medtech%20Insights%20and%20Guardant%20Health.pngCAI Featured Article - Medtech Insights and Guardant HealthCAI Featured Article - Medtech Insights and Guardant Health2025-03-26https://www.concertai.com/publications/real-world-treatment-patterns-and-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-who-previously-progressed-from-metastatic-hormone-sensitive2026-08-18https://www.concertai.com/how-we-hirehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_4-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Group%20Photo.pngGroup PhotoGroup Photohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF4670-Enhanced-NR.jpgDSCF4670-Enhanced-NRDSCF4670-Enhanced-NRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_1586-2.jpgIMG_1586-2IMG_1586-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/processed-EB263BCB-F8E5-4B3F-A8B3-310154CCDE1C-75C3835F-B945-4029-88A4-73EF1025FDC7-2.jpgprocessed-EB263BCB-F8E5-4B3F-A8B3-310154CCDE1C-75C3835F-B945-4029-88A4-73EF1025FDC7-2processed-EB263BCB-F8E5-4B3F-A8B3-310154CCDE1C-75C3835F-B945-4029-88A4-73EF1025FDC7-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/shared%20image%20(41).jpgshared image (41)shared image (41)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_3217.jpgIMG_3217IMG_3217https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Social/ITEM%20Booth%202026-crop.jpgITEM Booth 2026-cropITEM Booth 2026-crophttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Interview%20Hiring.pngCAI Interview HiringCAI Interview Hiringhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/social-suggested-images/20250531_084051-crop.jpg20250531_084051-crop20250531_084051-crophttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_3850.jpgIMG_3850IMG_3850https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/shared%20image%20(43).jpgshared image (43)shared image (43)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF7746.jpgDSCF7746DSCF7746https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF0939.jpgDSCF0939DSCF0939https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Connect%20Hiring.pngCAI Connect HiringCAI Connect Hiringhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Apply%20Hiring.pngCAI Apply HiringCAI Apply Hiringhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSCF4415-2.jpgDSCF4415-2DSCF4415-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Decision%20Hiring.pngCAI Decision HiringCAI Decision Hiringhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/FullSizeRender-5.jpgFullSizeRender-5FullSizeRender-5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Research%20Hiring.pngCAI Research HiringCAI Research Hiringhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Cover%202%20(1).pngConcertAI Cover 2 (1)ConcertAI Cover 2 (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/IMG_9606.jpgIMG_9606IMG_9606https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SCOPE%202026%20Team%20Photo-2.jpgSCOPE 2026 Team Photo-2SCOPE 2026 Team Photo-22026-07-16https://www.concertai.com/publications/impact-of-trial-site-selection-on-minority-patient-recruitment-in-prostate-cancer-trials2026-08-18https://www.concertai.com/publications/clinical-and-molecular-predictors-of-response-to-lu-177-psma-617-in-metastatic-castration-resistant-prostate-cancer2026-08-18https://www.concertai.com/publications/site-of-metastasis-som-and-its-impact-on-clinical-outcomes-in-8-cancer-cohorts2026-08-18https://www.concertai.com/events/ispor-2024/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/publications/survival-outcomes-of-apa-as-a-starting-treatment-impact-in-real-world-patients-with-mcspc-oasis2026-08-18https://www.concertai.com/publications/2024/03/artificial-intelligence-model-to-predict-slow-progression-for-advanced-non-small-cell-lung-cancer-ansclc-patients-receiving-second-line-therapies/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/2024/03/development-of-an-artificial-intelligence-model-to-dynamically-predict-metastatic-recurrence-of-early-stage-breast-cancer-patients/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/asco2024-post-showhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/eScreening%20(Sponsors)%20Cover.jpgeScreening (Sponsors) CovereScreening (Sponsors) Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/EMR2EDC%20(Sponsors)%20Cover.jpgEMR2EDC (Sponsors) CoverEMR2EDC (Sponsors) Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient360%20FAST%20Cover.jpgPatient360 FAST CoverPatient360 FAST Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/EMR2EDC%20(Providers)%20Cover.jpgEMR2EDC (Providers) CoverEMR2EDC (Providers) Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon%20-%20Accelerated%20Patient%20Enrollment.svgIcon - Accelerated Patient EnrollmentIcon - Accelerated Patient Enrollmenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/eScreening%20(Providers)%20Cover.jpgeScreening (Providers) CovereScreening (Providers) Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon%20-%20Translation%20to%20Evidence.svgIcon - Translation to EvidenceIcon - Translation to Evidencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20PR%20Poster%20-%20Olaparib%20(1).pngASCO PR Poster - Olaparib (1)ASCO PR Poster - Olaparib (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/MKM-Factsheet-OncologySuite-31May2024_Page_1.jpgMKM-Factsheet-OncologySuite-31May2024_Page_1MKM-Factsheet-OncologySuite-31May2024_Page_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-v2-5054.pngCAI ASCO Publications-v2-5054CAI ASCO Publications-v2-5054https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TriaLinQ%20Cover.jpgTriaLinQ CoverTriaLinQ Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon%20-%20Definitive%20Quality%20and%20Utility.svgIcon - Definitive Quality and UtilityIcon - Definitive Quality and Utilityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-v2-1158.pngCAI ASCO Publications-v2-1158CAI ASCO Publications-v2-1158https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%202024%20-%20thank%20you%20page.pngASCO 2024 - thank you pageASCO 2024 - thank you pagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon-Secure%20Cloud%20Access1.svgIcon-Secure Cloud Access1Icon-Secure Cloud Access1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Life%20Sciences%20Platform%20Cover.pngLife Sciences Platform CoverLife Sciences Platform Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient360%20Cover.pngPatient360 CoverPatient360 Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-v2-e13641.pngCAI ASCO Publications-v2-e13641CAI ASCO Publications-v2-e13641https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CLQ%20ASCO%20Publications%20v2%20-e23237.pngCLQ ASCO Publications v2 -e23237CLQ ASCO Publications v2 -e23237https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Neo%20Cover.jpgNeo CoverNeo Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NVIDIA%20Collaboration%20PR.pngNVIDIA Collaboration PRNVIDIA Collaboration PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2024%20CAI%20ASCO%20-%20Rectangle-%20Study%203x%20faster.png2024 CAI ASCO - Rectangle- Study 3x faster2024 CAI ASCO - Rectangle- Study 3x fasterhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20PR%20Poster%20-%202-4x%20times-1.pngASCO PR Poster - 2-4x times-1ASCO PR Poster - 2-4x times-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SmartLinQ%20Cover.jpgSmartLinQ CoverSmartLinQ Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Caris%20Cover.jpgCaris CoverCaris Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon%20-%20Trial%20Design%20and%20Simulation.svgIcon - Trial Design and SimulationIcon - Trial Design and Simulationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CLQ%20ASCO%20Publications%20v2%20-4169.pngCLQ ASCO Publications v2 -4169CLQ ASCO Publications v2 -4169https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20ASCO%20Publications-v2-e13636.pngCAI ASCO Publications-v2-e13636CAI ASCO Publications-v2-e13636https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jeff%20Elton.pngJeff EltonJeff Eltonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20PR%20Poster%20-%20Multi-AI%20model%20(1).pngASCO PR Poster - Multi-AI model (1)ASCO PR Poster - Multi-AI model (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Robert%20Miller.pngRobert MillerRobert Millerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon-Scale%20Representativeness.svgIcon-Scale RepresentativenessIcon-Scale Representativenesshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Clinical%20Trial%20Optimization%20Coger.pngClinical Trial Optimization CogerClinical Trial Optimization Cogerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon%20-%20High%20Recency%20Refresh.svgIcon - High Recency RefreshIcon - High Recency Refreshhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PathAI%20Cover.jpgPathAI CoverPathAI Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RxLinQ%20Cover.jpgRxLinQ CoverRxLinQ Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/social-suggested-images/ASCO%202024%20PR%20-%20General.pngASCO 2024 PR - GeneralASCO 2024 PR - Generalhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CLQ%20ASCO%20Publications%20v2%20-e13739.pngCLQ ASCO Publications v2 -e13739CLQ ASCO Publications v2 -e13739https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RWD360%20Cover-1.pngRWD360 Cover-1RWD360 Cover-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Genome360%20Cover-1.jpgGenome360 Cover-1Genome360 Cover-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/social-suggested-images/Thank%20you%20ASCO%2024%20CAI.pngThank you ASCO 24 CAIThank you ASCO 24 CAIhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Icon%20-%20GenAI%20NLP%20Integration.svgIcon - GenAI NLP IntegrationIcon - GenAI NLP Integration2024-06-11https://www.concertai.com/publications/unfavorable-early-stage-hodgkin-lymphoma-assessment-of-patient-characteristics-in-a-real-world-setting2026-08-18https://www.concertai.com/news/2024/01/concertai-to-present-at-the-42nd-annual-j-p-morgan-healthcare-conferencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/2-Weeks-Until-JP-Morgan-December-2023-3.png2-Weeks-Until-JP-Morgan-December-2023-32-Weeks-Until-JP-Morgan-December-2023-32024-03-06https://www.concertai.com/news/2024/01/neogenomics-and-concertai-collaboration-announcementhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-29.pngArtboard-1-copy-29Artboard-1-copy-29https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-06https://www.concertai.com/blog/2024/03/community-oncology-viability-assures-patient-access-equity-safety-and-innovationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Community-Oncology-Viability-Blog.pngCommunity-Oncology-Viability-BlogCommunity-Oncology-Viability-Bloghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-26https://www.concertai.com/publications/racial-and-ethnic-representation-in-large-b-cell-lymphoma-trials-and-real-world-databases2026-08-18https://www.concertai.com/publications/real-world-study-of-use-patterns-and-clinical-outcomes-for-patients-with-myelodysplastic-syndrome-initiating-oral-decitabine-and-cedazuridine-or-intravenous2026-08-18https://www.concertai.com/publications/natural-history-and-real-world-treatment-outcomes-for-non-small-cell-lung-cancer-patients-with-egfr-exon-20-insertion-mutation-an-iaslc-asco-cancerlinq-study2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-clinical-outcomes-among-cholangiocarcinoma-patients-treated-with-futibatinib-or-pemigatinib2026-08-18https://www.concertai.com/publications/treatment-patterns-and-clinical-outcomes-among-patients-with-relapsed-refractory-classical-hodgkin-s-lymphoma2026-08-18https://www.concertai.com/publications/training-and-validation-of-caraai-a-multi-llm-platform-and-data-model-to-address-oncology-specific-challenges-in-clinical-data-extraction2026-08-18https://www.concertai.com/publications/rapid-and-deep-prostate-specific-antigen-psa-response-to-apalutamide-plus-adt-and-survival-in-metastatic-castration-sensitive-prostate-cancer-mcspc-in-real-world2026-08-18https://www.concertai.com/publications/outcomes-for-patients-with-chronic-lymphocytic-leukemia-cll-previously-treated-with-both-a-covalent-btk-and-bcl2-inhibitor-in-the-united-states-a-real-world-database2026-08-18https://www.concertai.com/publications/quantification-of-information-gained-by-linking-claims-data-to-an-electronic-health-record-cohort-of-patients-with-metastatic-breast-cancer2026-08-18https://www.concertai.com/publications/clinical-characteristics-and-treatment-of-patients-with-small-cell-prostate-cancer-analysis-of-a-real-world-cohort-from-an-oncology-database2026-08-18https://www.concertai.com/job-posting/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/blog/2023/04/why-clinical-trials-will-never-be-the-samehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/whyClinicalTrialsWillNeverBeTheSame-1-2.pngwhyClinicalTrialsWillNeverBeTheSame-1-2whyClinicalTrialsWillNeverBeTheSame-1-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-17https://www.concertai.com/news/concertai-and-neogenomics-announce-new-ai-software-as-a-service-solution-for-hematology-clinical-researchhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2024%20CAI%20ASCO%20-%20Rectangle%20(5).png2024 CAI ASCO - Rectangle (5)2024 CAI ASCO - Rectangle (5)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-12-05https://www.concertai.com/publications/a-machine-learning-model-to-facilitate-patient-level-risk-screening-in-myelodysplastic-syndromes-mds-patients-in-routine-clinical-practice2026-08-18https://www.concertai.com/publications/association-of-clinical-trial-enrollment-and-mortality-amongst-patients-with-advanced-prostate-cancer2026-08-18https://www.concertai.com/publications/2024/03/characteristics-of-patients-treated-with-fulvestrant-as-first-hormonal-therapy-for-metastatic-breast-cancer-in-a-real-world-setting/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/blog/translational360-for-decision-ready-evidence-concertaihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Translational360%20Blog.pngTranslational360 BlogTranslational360 Bloghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-05-13https://www.concertai.com/news/at-scope-2025-concertai-announces-major-advances-in-trial-technologies-for-research-sites-and-sponsorshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20SCOPE%202025.pngConcertAI Press Release SCOPE 2025ConcertAI Press Release SCOPE 2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-02-03https://www.concertai.com/request-information/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Request%20a%20Demo.jpgRequest a DemoRequest a Demohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-27https://www.concertai.com/publications/2024/03/thrive-study-protocol-a-randomized-controlled-trial-evaluating-a-web-based-app-and-tailored-messages-to-improve-adherence-to-adjuvanthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/asco-qcs-2020https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/publications/2024/03/occurrence-of-brain-metastasis-and-treatment-patterns-among-patients-with-her2-positive-metastatic-breast-cancer/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/leveraging-real-world-data-sources-for-clinical-oncology-research-a-review-of-studies-published-in-asco-publications2026-08-18https://www.concertai.com/publications/real-world-use-patterns-effectiveness-and-tolerability-of-sacituzumab-govitecan-for-second-line-and-later-line-treatment-of-metastatic-triple-negative-breast-cancer-in2026-08-18https://www.concertai.com/publications/electronic-health-record-ehr-and-genomics-based-machine-learning-ml-to-predict-therapeutic-effectiveness-among-patients-with-hormone-receptor-positive-hr-plus-her22026-08-18https://www.concertai.com/publications/long-term-survival-outcomes-in-nsclc-patients-with-targeted-therapy-and-immunotherapy-an-iaslc-analysis-of-asco-cancerlinq-discovery-data2026-08-18https://www.concertai.com/publications/real-world-evidence-provides-clinical-insights-into-tissue-agnostic-therapeutic-approvals2026-08-18https://www.concertai.com/blog/building-the-trustworthy-data-foundation-for-healthcare-aihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Blog%20Building%20Trustworthy%20Data%20Foundation%20for%20Healthcare%20AI.pngBlog Building Trustworthy Data Foundation for Healthcare AIBlog Building Trustworthy Data Foundation for Healthcare AIhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-06-30https://www.concertai.com/publications/2024/03/machine-learning-approach-to-understand-real-world-treatment-in-patients-with-higher-risk-myelodysplastic-syndromes/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/real-world-treatment-patterns-testing-patterns-and-clinical-outcomes-of-first-line-1l-therapy-for-metastatic-gastric-cancer-gastroesophageal-junction-cancer-or2026-08-18https://www.concertai.com/redesign-temphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Artboard-2.pngArtboard-2Artboard-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20GTM%20-%20Pic%201.pngPrecision GTM - Pic 1Precision GTM - Pic 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Intro%20Splash%20Original%202.gifConcertAI Intro Splash Original 2ConcertAI Intro Splash Original 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Dr%20Glen%20Schlaphoff%20-%20Doc%20Talks%20%20(3).pngDr Glen Schlaphoff - Doc Talks (3)Dr Glen Schlaphoff - Doc Talks (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Screenshot%202025-03-29%20at%202.52.05%20AM.pngScreenshot 2025-03-29 at 2.52.05 AMScreenshot 2025-03-29 at 2.52.05 AMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screenshot-mod-2.pngscreenshot-mod-2screenshot-mod-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/1Artboard%2025%20copy.png1Artboard 25 copy1Artboard 25 copyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20-%20Pic%202.pngPrecision Explorer - Pic 2Precision Explorer - Pic 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Screenshot%202025-04-16%20at%201.39.14%20PM.pngScreenshot 2025-04-16 at 1.39.14 PMScreenshot 2025-04-16 at 1.39.14 PM2025-04-17https://www.concertai.com/news/dhiraj-carumbaya-joins-concertai-as-senior-vice-president-and-general-manager-of-terareconhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Dhiraj%20Carumbaya%20PR%20(2).pngDhiraj Carumbaya PR (2)Dhiraj Carumbaya PR (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-05-16https://www.concertai.com/publications/treatment-patterns-and-survival-by-race-among-men-with-metastatic-castration-resistant-prostate-cancer-mcrpc-in-the-united-states-a-us-electronic-medical-record2026-08-18https://www.concertai.com/publications/real-world-outcomes-among-patients-with-metastatic-colorectal-cancer-treated-first-line-with-bevacizumab-awwb2026-08-18https://www.concertai.com/publications/chasm-between-cancer-quality-measures-and-electronic-health-record-data-quality2026-08-18https://www.concertai.com/publications/challenges-to-using-big-data-in-cancer2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-healthcare-resource-utilization-in-patients-with-waldenstrom-macroglobulinemia-initiating-first-line-treatment-with-ibrutinib-or2026-08-18https://www.concertai.com/cancerlinq-suitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop01-02-CancerLinQi.mp4/medium.jpgCAI-BGLoop01-02-CancerLinQiCAI-BGLoop01-02-CancerLinQihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop01-02-CancerLinQi.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CancerLinQ%20Suite-1.mp4/medium.jpgCancerLinQ Suite-1CancerLinQ Suite-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CancerLinQ%20Suite-1.mp4121nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SmartLinQ%201.pngSmartLinQ 1SmartLinQ 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-app-sandbox-sandbox-cancerlinq-io-reports-2026-04-27-13_39_46.pngscreencapture-app-sandbox-sandbox-cancerlinq-io-reports-2026-04-27-13_39_46screencapture-app-sandbox-sandbox-cancerlinq-io-reports-2026-04-27-13_39_46https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TriaLinQ%201.pngTriaLinQ 1TriaLinQ 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-app-demo-stage-cancerlinq-io-patient-viewer-2026-04-27-13_45_13%20(1)-1.pngscreencapture-app-demo-stage-cancerlinq-io-patient-viewer-2026-04-27-13_45_13 (1)-1screencapture-app-demo-stage-cancerlinq-io-patient-viewer-2026-04-27-13_45_13 (1)-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Microsoft%20Teams%20Background%20v8-1.pngMicrosoft Teams Background v8-1Microsoft Teams Background v8-12026-07-10https://www.concertai.com/publications/real-world-rw-use-patterns-effectiveness-and-tolerability-of-sacituzumab-govitecan-sg-for-second-line-2l-and-later-treatment-of-metastatic-triple-negative-breast-cancer2026-08-18https://www.concertai.com/precision-explorer_oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer_4K.mp4/medium.jpgPrecision Explorer_4KPrecision Explorer_4Khttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer_4K.mp482nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SoC%20to%20RW%20Treatment%20Progression%20Comparison-1.pngSoC to RW Treatment Progression Comparison-1SoC to RW Treatment Progression Comparison-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Speed%202.svgSpeed 2Speed 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Curation%20(Pink).svgCuration (Pink)Curation (Pink)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Social%20SQ.pngPrecision360 Social SQPrecision360 Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/real%20world%20ready.svgreal world readyreal world readyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%201.svgAsset 1Asset 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Population%20Comorbidities%20Analysis.pngPopulation Comorbidities AnalysisPopulation Comorbidities Analysishttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20WWO.pngPrecision Explorer WWOPrecision Explorer WWOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Overall%20Survival%20(OS)%20Analysis.pngOverall Survival (OS) AnalysisOverall Survival (OS) Analysishttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20Banner.pngPrecision Explorer BannerPrecision Explorer Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Explore%20RWD%20with%20Natural%20Language.pngExplore RWD with Natural LanguageExplore RWD with Natural Language2026-05-27https://www.concertai.com/publications/real-world-effectiveness-of-frontline-treatments-among-patients-with-chronic-lymphocytic-leukemia-results-from-concertai2026-08-18https://www.concertai.com/publications/using-ai-methodology-to-stack-and-harmonize-two-u-s-emr-databases2026-08-18https://www.concertai.com/25homehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai_-_generative_&_agentic_ai_leader%20(2160p).mp4/medium.jpgconcertai_-_generative_&_agentic_ai_leader (2160p)concertai_-_generative_&_agentic_ai_leader (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai_-_generative_&_agentic_ai_leader%20(2160p).mp4113nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-hero-video.mov/medium.jpgconcertai-hero-videoconcertai-hero-videohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-hero-video.mov20nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/asembia_2025_video_update_v1%20(2160p)%20(1).mp4/medium.jpgasembia_2025_video_update_v1 (2160p) (1)asembia_2025_video_update_v1 (2160p) (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/asembia_2025_video_update_v1%20(2160p)%20(1).mp489nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/homepage-hero-bg.mp4/medium.jpghomepage-hero-bghomepage-hero-bghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/homepage-hero-bg.mp415nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision-Copilot.mov/medium.jpgPrecision-CopilotPrecision-Copilothttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision-Copilot.mov15nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20at%20NVIDIA%20GTC.mp4/medium.jpgConcertAI at NVIDIA GTCConcertAI at NVIDIA GTChttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20at%20NVIDIA%20GTC.mp422nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Copilot%20NEW%20ASCO.webm/medium.jpgPrecision Copilot NEW ASCOPrecision Copilot NEW ASCOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Copilot%20NEW%20ASCO.webm15nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Homepage%20Cards%20(ASCO).webm/medium.jpgHomepage Cards (ASCO)Homepage Cards (ASCO)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Homepage%20Cards%20(ASCO).webm0nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%202025%20Videos/Precision%20Copilot%20Animation%20v2.mp4/medium.jpgPrecision Copilot Animation v2Precision Copilot Animation v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%202025%20Videos/Precision%20Copilot%20Animation%20v2.mp412nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(48)-1.pngUntitled design (48)-1Untitled design (48)-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NHS%20England.svgNHS EnglandNHS Englandhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20BG.pngPrecision360 BGPrecision360 BGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/bristol.svgbristolbristolhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20GTM%20BG.pngPrecision GTM BGPrecision GTM BGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/thumb%20(17).jpgthumb (17)thumb (17)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/abbvie.svgabbvieabbviehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/thumb%20(15).jpgthumb (15)thumb (15)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/17.png1717https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20BG.pngPrecision Trials BGPrecision Trials BGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DTS-1.jpgDTS-1DTS-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/16.png1616https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Mayo%20Clinic%20Home%20Page.svgMayo Clinic Home PageMayo Clinic Home Pagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Genentech%20(White).svgGenentech (White)Genentech (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Temple%20Health%20Logo%20(2).svgTemple Health Logo (2)Temple Health Logo (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Lilly%20White.svgLilly WhiteLilly Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/precision-trials-img.pngprecision-trials-imgprecision-trials-imghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/HSC%20Logo%20White.pngHSC Logo WhiteHSC Logo Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/18.png1818https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Logo%20of%20University%20of%20Maryland%20Medical%20Center%20(1).svgLogo of University of Maryland Medical Center (1)Logo of University of Maryland Medical Center (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amgen%20Logo%20White.svgAmgen Logo WhiteAmgen Logo Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/precision-gtm.pngprecision-gtmprecision-gtmhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Geisinger%20Logo.svgGeisinger LogoGeisinger Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/logo-atrium-white-svg.svglogo-atrium-white-svglogo-atrium-white-svghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Penn%20Medicine%20Home.svgPenn Medicine HomePenn Medicine Homehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Astellas%20White.svgAstellas WhiteAstellas Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Merck%20(White).svgMerck (White)Merck (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Otsuka_Holdings_logo%20(White).svgOtsuka_Holdings_logo (White)Otsuka_Holdings_logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Lilly%20Logo%20(White).svgLilly Logo (White)Lilly Logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/logo-mgh--white.svglogo-mgh--whitelogo-mgh--whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon-1.jpgTeraRecon-1TeraRecon-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AstraZeneca.svgAstraZenecaAstraZenecahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/precision-explorer-img.pngprecision-explorer-imgprecision-explorer-imghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/bayer.svgbayerbayerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cadence%20Suite%20Banner.pngCadence Suite BannerCadence Suite Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/wq%20(15)%20(edited)-1.jpgwq (15) (edited)-1wq (15) (edited)-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/novartis.svgnovartisnovartishttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Regeneron.svgRegeneronRegeneronhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Splash%202025%20GIF.gifConcertAI Splash 2025 GIFConcertAI Splash 2025 GIFhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Nebras%20H%20Lo%20(Whi).svgNebras H Lo (Whi)Nebras H Lo (Whi)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/thumb%20(16).jpgthumb (16)thumb (16)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20BG-3.pngPrecision Explorer BG-3Precision Explorer BG-3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Sanofi%20(White).svgSanofi (White)Sanofi (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/precision360-logo.svgprecision360-logoprecision360-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/15.png1515https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CancerLinQ-1.jpgCancerLinQ-1CancerLinQ-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Commercial-Solutions-1.jpgCommercial-Solutions-1Commercial-Solutions-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RWE-1.jpgRWE-1RWE-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/duke_logo.svgduke_logoduke_logo2026-05-27https://www.concertai.com/publications/comparing-prospectively-assigned-trial-and-real-world-lung-cancer-patients2026-08-18https://www.concertai.com/terarecon-detecthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Terarecon%20DETECT%20(2).mp4/medium.jpgTerarecon DETECT (2)Terarecon DETECT (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Terarecon%20DETECT%20(2).mp4108nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20DETECT%20(9).pngTeraRecon DETECT (9)TeraRecon DETECT (9)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TR%20Detect%20SG.png-1.pngTR Detect SG.png-1TR Detect SG.png-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_3.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_3CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Detect/DETECT%20plaque%20analysis%2016%20x%209.pngDETECT plaque analysis 16 x 9DETECT plaque analysis 16 x 9https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Detect/DETECT%20fatty%20liver%2016%20x%209.pngDETECT fatty liver 16 x 9DETECT fatty liver 16 x 92026-07-27https://www.concertai.com/our-locationshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Cover%202%20(1).pngConcertAI Cover 2 (1)ConcertAI Cover 2 (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_1.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_1CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Map%20for%20office.svgMap for officeMap for office2026-07-16https://www.concertai.com/concertai-fact-sheetshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-03https://www.concertai.com/publications/2024/03/cost-and-healthcare-resource-utilization-hcru-for-patients-receiving-neoadjuvant-therapy-for-early-stage-triple-negative-breast-cancer-estnbc/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/asco-ispor-2020-researchhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/hero-advancing-ai@1.5x.jpghero-advancing-ai@1.5xhero-advancing-ai@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Joanne_PCM-asco-abstract_1st-recording-thumb.jpegJoanne_PCM-asco-abstract_1st-recording-thumbJoanne_PCM-asco-abstract_1st-recording-thumbhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Deep-Learning-Model.jpgDeep-Learning-ModelDeep-Learning-Modelhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Smita_impute-lung-cancer-subtype_video-final-thumb.jpegSmita_impute-lung-cancer-subtype_video-final-thumbSmita_impute-lung-cancer-subtype_video-final-thumbhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Vivek_2_mBC-Recurrence_video-final-thumb.jpegVivek_2_mBC-Recurrence_video-final-thumbVivek_2_mBC-Recurrence_video-final-thumbhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Cardiac-Adverse-Event-in-NSCLC_video-thumb-2.jpegCardiac-Adverse-Event-in-NSCLC_video-thumb-2Cardiac-Adverse-Event-in-NSCLC_video-thumb-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Mark_Proxy20vs20Direct20Measures_video20final-thumb.jpegMark_Proxy20vs20Direct20Measures_video20final-thumbMark_Proxy20vs20Direct20Measures_video20final-thumbhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Francois_Slow-Progressors_asco-abstract-video-thumb-1.jpegFrancois_Slow-Progressors_asco-abstract-video-thumb-1Francois_Slow-Progressors_asco-abstract-video-thumb-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-08-05https://www.concertai.com/publications/real-world-outcomes-among-her2-positive-metastatic-breast-cancer-patients-treated-with-trastuzumab-deruxtecan-in-the-united-states2026-08-18https://www.concertai.com/contenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2025-05-29https://www.concertai.com/publications/real-world-homologous-recombination-repair-mutation-hrrm-testing-patterns-in-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-treated-with-olaparib2026-08-18https://www.concertai.com/publications/streamline-retrospective-cohort-study-of-flt3-mutated-acute-myeloid-leukemia-aml-real-world-treatment-patterns-and-clinical-outcomes-after-first-relapse-or-refractory-r2026-08-18https://www.concertai.com/news/concertai-presents-at-43rd-annual-j.p.-morgan-healthcare-conferencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2024%20CAI%20ASCO%20-%20Rectangle%20(8).png2024 CAI ASCO - Rectangle (8)2024 CAI ASCO - Rectangle (8)2025-01-13https://www.concertai.com/cto_hhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(2)-2.pngUntitled design (2)-2Untitled design (2)-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Neo%20Cover%20(1).jpgNeo Cover (1)Neo Cover (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/View-Press-Release-Button.pngView-Press-Release-ButtonView-Press-Release-Buttonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient-Onboarding-Success.svgPatient-Onboarding-SuccessPatient-Onboarding-Successhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Request-a-Demo-Button.pngRequest-a-Demo-ButtonRequest-a-Demo-Buttonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Hit%20Consultant%20(2).pngHit Consultant (2)Hit Consultant (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20NEO%20Top.svgCAI NEO TopCAI NEO Tophttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/mutations%20ASH%20publication.pngmutations ASH publicationmutations ASH publicationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/bakground%201.pngbakground 1bakground 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/GenomeWeb%20(1).pngGenomeWeb (1)GenomeWeb (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AI%20tech%20park%20(3).pngAI tech park (3)AI tech park (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/continuity.svgcontinuitycontinuityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Updated%20-%20%202024%20CAI%20ASCO%20-%20Rectangle%20(7).pngUpdated - 2024 CAI ASCO - Rectangle (7)Updated - 2024 CAI ASCO - Rectangle (7)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Updated%20-%20%202024%20CAI%20ASCO%20-%20CTO-H.pngUpdated - 2024 CAI ASCO - CTO-HUpdated - 2024 CAI ASCO - CTO-Hhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Data-Unsupervised-Learning-Variable-Diversity.svgData-Unsupervised-Learning-Variable-DiversityData-Unsupervised-Learning-Variable-Diversityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%201.svgAsset 1Asset 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Updated%20-%20%202024%20CAI%20ASCO%20-%20Rectangle%20(8).pngUpdated - 2024 CAI ASCO - Rectangle (8)Updated - 2024 CAI ASCO - Rectangle (8)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Untitled%20design%20(3).pngUntitled design (3)Untitled design (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Real%20world%20use%20patterns%20ash%20publication.pngReal world use patterns ash publicationReal world use patterns ash publicationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Updated%20-%20%202024%20CAI%20ASCO%20-%20Rectangle%20(5).pngUpdated - 2024 CAI ASCO - Rectangle (5)Updated - 2024 CAI ASCO - Rectangle (5)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI%20Neo%20Thing-1.pngCAI Neo Thing-1CAI Neo Thing-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/real%20world%20treatment%20ASH%20publication.pngreal world treatment ASH publicationreal world treatment ASH publication2025-06-30https://www.concertai.com/blog/2023/04/the-concert-podcast-clinical-development-technologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PM.pngConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PMConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Juke-Dunlap-and-Jeff-Elton-scaled-1.jpgJuke-Dunlap-and-Jeff-Elton-scaled-1Juke-Dunlap-and-Jeff-Elton-scaled-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Luke-Dunlap-768x1024-1.jpgLuke-Dunlap-768x1024-1Luke-Dunlap-768x1024-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM.pngConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM2024-03-17https://www.concertai.com/events/artificial-intelligence-health-equity-feat-warren-whyte-nick-kenny/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-12024-03-26https://www.concertai.com/events/innovation-through-digitization-disrupting-the-clinical-trial-landscape/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubled2024-03-26https://www.concertai.com/publications/real-world-treatment-and-clinical-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-olaparib-in-the-united-states2026-08-18https://www.concertai.com/publications/patient-characteristics-treatment-patterns-and-factors-of-biomarker-testing-among-patients-with-advanced-non-small-cell-lung-cancer-ansclc-in-the-us-2012-20202026-08-18https://www.concertai.com/publications/survival-of-patients-with-multiple-myeloma-diagnosed-with-second-primary-malignancies-an-asco-cancerlinq-analysis2026-08-18https://www.concertai.com/cadence-suitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai_-_cadence_suite_(subs)_v4%20(2160p).mp4/medium.jpgconcertai_-_cadence_suite_(subs)_v4 (2160p)concertai_-_cadence_suite_(subs)_v4 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai_-_cadence_suite_(subs)_v4%20(2160p).mp4194nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-cadence-demo-concertai-patient-compass-2026-04-17-15_10_39-1.pngscreencapture-cadence-demo-concertai-patient-compass-2026-04-17-15_10_39-1screencapture-cadence-demo-concertai-patient-compass-2026-04-17-15_10_39-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cadence%20Suite%20-%20SP%20Benchmarking-1.pngCadence Suite - SP Benchmarking-1Cadence Suite - SP Benchmarking-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-cadence-demo-concertai-market-intelligence-2026-04-17-15_11_07-1.pngscreencapture-cadence-demo-concertai-market-intelligence-2026-04-17-15_11_07-1screencapture-cadence-demo-concertai-market-intelligence-2026-04-17-15_11_07-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_4.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_4CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_4https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-cadence-demo-concertai-inventory-assistant-2026-04-17-15_11_46-1.pngscreencapture-cadence-demo-concertai-inventory-assistant-2026-04-17-15_11_46-1screencapture-cadence-demo-concertai-inventory-assistant-2026-04-17-15_11_46-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-cadence-demo-concertai-frm-poc-2026-04-17-15_11_31-1.pngscreencapture-cadence-demo-concertai-frm-poc-2026-04-17-15_11_31-1screencapture-cadence-demo-concertai-frm-poc-2026-04-17-15_11_31-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CADENCE%20SUITE.pngCADENCE SUITECADENCE SUITE2026-05-28https://www.concertai.com/publications/real-world-treatment-patterns-recurrence-and-overall-survival-of-patients-with-muscle-invasive-bladder-cancer-undergoing-radical-cystectomy-in-u-s-oncology-practice2026-08-18https://www.concertai.com/publications/real-world-second-line-outcomes-of-nsclc-patients-receiving-first-line-chemotherapy-plus-immunotherapy2026-08-18https://www.concertai.com/publications/predicting-real-world-overall-survival-in-advanced-melanoma-using-machine-learning2026-08-18https://www.concertai.com/publications/evaluation-of-treatment-strategies-for-patients-with-stage-iiia-non-small-cell-lung-cancer-in-the-immunotherapy-era-20232026-08-18https://www.concertai.com/escreening-for-providers-fact-sheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Fact-Sheet-Display_eScreening-Providers.pngFact-Sheet-Display_eScreening-ProvidersFact-Sheet-Display_eScreening-Providershttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/publications/molecular-testing-and-patterns-of-treatment-in-nsclc-patients-an-iaslc-analysis-of-asco-cancerlinq-discovery-data2026-08-18https://www.concertai.com/publications/luminate-103-real-world-treatment-patterns-and-outcomes-of-patients-pts-with-epidermal-growth-factor-receptor-mutant-egfr-mu-non-squamous-nsq-locally-advanced2026-08-18https://www.concertai.com/publications/a-real-world-study-on-biomarker-retesting-among-patients-with-non-small-cell-lung-cancer-and-disparity-in-outcomes2026-08-18https://www.concertai.com/accelerated-commercial-outcomes-suitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2033.svgAsset 33Asset 33https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Alerts%20(1).pngAlerts (1)Alerts (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2032.svgAsset 32Asset 32https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACO%20Social%20SQ%20(1).pngACO Social SQ (1)ACO Social SQ (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2031.svgAsset 31Asset 31https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Real%20Time.svgReal TimeReal Timehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACO%20Suite%20Cover%20(1).pngACO Suite Cover (1)ACO Suite Cover (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Explorer%20(1).pngCARAai Explorer (1)CARAai Explorer (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Profile%20(1).pngPatient Profile (1)Patient Profile (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Engagement%20Banner.pngPatient Engagement BannerPatient Engagement Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Dashboard%20(1).pngDashboard (1)Dashboard (1)2025-09-25https://www.concertai.com/advanced-visualization-oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials_4K.mp4/medium.jpgPrecision Trials_4KPrecision Trials_4Khttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials_4K.mp487nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20AI%20Partners%20(3).pngTeraRecon AI Partners (3)TeraRecon AI Partners (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon---Advanced-Visualizations-Page---Screen3.pngTeraRecon---Advanced-Visualizations-Page---Screen3TeraRecon---Advanced-Visualizations-Page---Screen3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Advanced%20Visualization%20TR.pngAdvanced Visualization TRAdvanced Visualization TRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20AI%20Partners%20(1).pngTeraRecon AI Partners (1)TeraRecon AI Partners (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Banner.pngTeraRecon BannerTeraRecon Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon---Advanced-Visualizations-Page---Screen1.pngTeraRecon---Advanced-Visualizations-Page---Screen1TeraRecon---Advanced-Visualizations-Page---Screen1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Intuition_4.7_Brochure_mockup.pngIntuition_4.7_Brochure_mockupIntuition_4.7_Brochure_mockuphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Infinitt.svgInfinittInfinitthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon---Advanced-Visualizations-Page---Screen2.pngTeraRecon---Advanced-Visualizations-Page---Screen2TeraRecon---Advanced-Visualizations-Page---Screen2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/dedalus.svgdedalusdedalushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/merative.svgmerativemerativehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/esaote.svgesaoteesaotehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20AI%20Partners-1.pngTeraRecon AI Partners-1TeraRecon AI Partners-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon---Partner-Showcase--BackgroundVector_UPT_2.jpgTeraRecon---Partner-Showcase--BackgroundVector_UPT_2TeraRecon---Partner-Showcase--BackgroundVector_UPT_2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon-1.jpgTeraRecon-1TeraRecon-12026-05-28https://www.concertai.com/publications/disparities-in-second-breast-cancer-events-and-survival-persist-despite-optimal-treatment-in-hormone-receptor-positive-breast-cancer-analysis-of-the-real-world2026-08-18https://www.concertai.com/events/a-clinical-trial-diversity-and-engagement-approach/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/eca-for-regulatory-submission-factsheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA-Fan.pngECA-FanECA-Fanhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/blog/2023/02/making-equity-and-diversity-realhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Making-Equity-and-Trial-Diversity-Real-Image-ConcertAI-1.pngMaking-Equity-and-Trial-Diversity-Real-Image-ConcertAI-1Making-Equity-and-Trial-Diversity-Real-Image-ConcertAI-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Jeff-Elton-Making-Equity-and-Trial-Diversity-Real-Banner-1.pngJeff-Elton-Making-Equity-and-Trial-Diversity-Real-Banner-1Jeff-Elton-Making-Equity-and-Trial-Diversity-Real-Banner-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-17https://www.concertai.com/news/concertai-presents-caraai-multi-llm-and-agentic-ai-for-clinical-development-and-insights-at-nvidia-gtc-2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20Nvidia%20GTC-18Mar2024.pngConcertAI Press Release Nvidia GTC-18Mar2024ConcertAI Press Release Nvidia GTC-18Mar2024https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-04-30https://www.concertai.com/terarecon-intuitionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/_Take%20a%20Tour/LDA%20II/Lung%20Segmentation.pngLung SegmentationLung Segmentationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/image-png-Nov-05-2025-09-35-44-5006-PM.pngimage-png-Nov-05-2025-09-35-44-5006-PMimage-png-Nov-05-2025-09-35-44-5006-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_12.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_12CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_12https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-07-27https://www.concertai.com/publications/real-world-outcomes-comparing-3-monthly-with-monthly-goserelin-implant-in-premenopausal-women-with-breast-cancer2026-08-18https://www.concertai.com/publications/characterizing-node-negative-non-small-cell-lung-cancer-patients-with-similarity-networks-a-cancerlinq-discovery-analysis2026-08-18https://www.concertai.com/publications/a-prospective-study-comparing-ai-based-clinical-trial-eligibility-screening-with-traditional-emr-based-screening2026-08-18https://www.concertai.com/publications/disease-free-and-overall-survival-outcomes-for-localized-rcc-patients-by-disease-stage2026-08-18https://www.concertai.com/publications/epidemiology-of-folate-receptor-alpha-expression-in-ovarian-cancer-by-age-race-ethnicity-and-histotype-in-a-real-world-us-based-clinicogenomic-database2026-08-18https://www.concertai.com/publications/2024/03/us-burden-of-illness-associated-with-adjuvant-therapy-for-stage-i-iii-melanoma/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/blog-examplehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/img-hero-blog@1.5x.jpgimg-hero-blog@1.5ximg-hero-blog@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2025-05-28https://www.concertai.com/blog/2024/02/the-concertai-podcast-empowering-community-oncology-challenges-innovations-feat-dr-sibel-blau-caroline-merillathttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Exigent-Podcast-Art-1.pngExigent-Podcast-Art-1Exigent-Podcast-Art-12024-03-17https://www.concertai.com/concertai-at-scopehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patrycja-Claudio-NEW-02-scaled.jpgPatrycja-Claudio-NEW-02-scaledPatrycja-Claudio-NEW-02-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us.svgMeet-With-UsMeet-With-Ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20at%20scope.svgConcertAI at scopeConcertAI at scopehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Factsheet-Fan.pngFactsheet-FanFactsheet-Fanhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Learn-More-Button.svgLearn-More-ButtonLearn-More-Buttonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/CAI-People-01-scaled.jpgCAI-People-01-scaledCAI-People-01-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard.jpgArtboardArtboard2024-03-29https://www.concertai.com/blog/2024/01/the-concertai-podcast-real-world-data-in-oncology-navigating-the-new-frontiers-feat-jennifer-riderhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Jennifer-Rider-Still-Promo-1.pngJennifer-Rider-Still-Promo-1Jennifer-Rider-Still-Promo-12024-03-17https://www.concertai.com/webinar_patient360-replay-lphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient-360-Webinar-Watch-Recording.pngPatient-360-Webinar-Watch-RecordingPatient-360-Webinar-Watch-Recordinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Warren-Whyte-New.pngWarren-Whyte-NewWarren-Whyte-New2024-03-29https://www.concertai.com/precision360_oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/18.png1818https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Continuously%20Learning.svgContinuously LearningContinuously Learninghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Fully%20Embedded.svgFully EmbeddedFully Embeddedhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision.svgPrecisionPrecisionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Mulitmodal.pngPrecision360 MulitmodalPrecision360 Mulitmodalhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Interoperability.pngPrecision360 InteroperabilityPrecision360 Interoperabilityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Homepage%20Image%202025.pngPrecision360 Homepage Image 2025Precision360 Homepage Image 2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/17.png1717https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Banner.pngPrecision360 BannerPrecision360 Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/19.png1919https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Cover.pngPrecision360 CoverPrecision360 Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Built%20for.svgBuilt forBuilt for2026-05-27https://www.concertai.com/publications/a-united-states-based-real-world-study-on-biomarker-testing-and-rebiopsy-rates-among-patients-with-non-small-cell-lung-cancer-across-lines-of-therapy2026-08-18https://www.concertai.com/publications/budget-impact-of-pirtobrutinib-for-patients-with-mantle-cell-lymphoma-mcl-or-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma-cll-sll-in-the-united-states-us2026-08-18https://www.concertai.com/publications/machine-learning-approach-to-understand-real-world-treatment-in-patients-with-higher-risk-myelodysplastic-syndromes2026-08-18https://www.concertai.com/publications/investigating-clinical-features-and-molecular-mechanisms-of-long-term-response-and-acquired-resistance-to-immunotherapy-in-non-small-cell-lung-cancer-by2026-08-18https://www.concertai.com/news/https/www.drugdiscoverytrends.com/nvidia-and-concertai-team-up-to-build-ai-agents-that-collaborate-on-oncology-trials/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/social-suggested-images/ConcertAI%20News-%20NVIDIA%20GTC%20DDD.pngConcertAI News- NVIDIA GTC DDDConcertAI News- NVIDIA GTC DDD2025-03-24https://www.concertai.com/publications/the-value-of-integrating-urology-and-oncology-real-world-data-for-understanding-prostate-cancer-management2026-08-18https://www.concertai.com/publications/addition-of-open-administrative-claims-significantly-improves-capture-of-mortality-in-electronic-health-record-ehr-focused-real-world-data-rwd2026-08-18https://www.concertai.com/publications/racial-differences-in-patient-reported-symptoms-and-adherence-to-adjuvant-endocrine-therapy-among-women-with-early-stage-hormone-receptor-positive-breast-cancer2026-08-18https://www.concertai.com/publications/machine-learning-ml-model-for-prediction-of-pneumonitis-using-real-world-data-rwd-on-immune-checkpoint-inhibitor-ici-treated-advanced-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/identifying-genetic-factors-of-response-and-resistance-to-cdk4-6-inhibitors-in-metastatic-hr-plus-her2-breast-cancer-using-real-world-data2026-08-18https://www.concertai.com/publications/comparison-of-advanced-ovarian-cancer-patients-treated-with-or-without-bevacizumab-in-the-us-community-oncology-clinics2026-08-18https://www.concertai.com/blog/2024/03/the-concertai-podcast-evolution-in-oncology-care-feat-george-sledge-phd-0-0-0https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Prostate%20Cancer%20Episode%201.pngProstate Cancer Episode 1Prostate Cancer Episode 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-09-17https://www.concertai.com/news/concertais-terarecon-detect-helps-identify-opportunities-to-optimize-ai-imaging-reimbursement-workflows-expanding-patient-access-to-the-most-advanced-carehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20TeraRecon%20DETECT.pngConcertAI Press Release TeraRecon DETECTConcertAI Press Release TeraRecon DETECThttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-11-20https://www.concertai.com/publications/2024/03/understanding-patient-advance-directives-status-in-a-community-oncology-practice-using-an-electronic-patient-reported-outcomes-epro-system/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/events/esmo-congress-2024/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/concertai-press-kithttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20Logo%20White%20Concert.pngConcertAI Logo White ConcertConcertAI Logo White Concerthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Erace%20Logo%20Dark.pngErace Logo DarkErace Logo Darkhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/The%20Clinic%20Ai%20&%20Real-World.pngThe Clinic Ai & Real-WorldThe Clinic Ai & Real-Worldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20Logo%20Full%20Color%20RGB.pngConcertAI Logo Full Color RGBConcertAI Logo Full Color RGBhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Concertai%20Press%20Kit%20text.pngConcertai Press Kit textConcertai Press Kit texthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20Logo%20SQ%20Press%20Blue%20Wave.pngConcertAI Logo SQ Press Blue WaveConcertAI Logo SQ Press Blue Wavehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Press%20Logo%20Images.pngPress Logo ImagesPress Logo Imageshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20CEO%20%E2%80%93%20Jeff%20Elton%2c%20PhD.jpgConcertAI CEO – Jeff Elton, PhDConcertAI CEO – Jeff Elton, PhDhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Concertai%20Press%20Kit.jpgConcertai Press KitConcertai Press Kithttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI%20Logo%20SQ-Press%20Hex%20Purple%20Wave.pngConcertAI Logo SQ-Press Hex Purple WaveConcertAI Logo SQ-Press Hex Purple Wavehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Erace%20Logo%20Light.pngErace Logo LightErace Logo Light2025-04-08https://www.concertai.com/publications/association-between-severe-adverse-event-management-and-overall-survival-in-patients-treated-with-immune-checkpoint-inhibitor-with-advanced-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/metpro-evaluating-prognostic-value-of-c-met-protein-overexpression-and-concurrent-biomarker-presence2026-08-18https://www.concertai.com/white-paper_optimizing-your-patient-analytics-capabilitieshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Whitepaper_Optimizing-Your-Patient-Analytics-Capabilities-791x1024.jpgWhitepaper_Optimizing-Your-Patient-Analytics-Capabilities-791x1024Whitepaper_Optimizing-Your-Patient-Analytics-Capabilities-791x1024https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/blog/cancerlinq-one-year-laterhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/World%20Lung%20Cancer%20Day-CLQ-V1.pngWorld Lung Cancer Day-CLQ-V1World Lung Cancer Day-CLQ-V1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-12-11https://www.concertai.com/publications/social-determinants-of-health-sdoh-and-z-code-utilization-among-patients-with-breast-cancer-bc2026-08-18https://www.concertai.com/publications/2024/03/clinical-outcomes-among-patients-with-unresected-stage-iii-non-small-cell-lung-cancer-nsclc-in-a-real-world-setting/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/real-world-big-data-strengths-and-weaknesses-of-asco-s-cancerlinq-discovery-multiple-myeloma-dataset2026-08-18https://www.concertai.com/publications/enhancement-in-line-of-therapy-lot-derivation-from-real-world-data-rwd-from-electronic-health-records-ehr-via-integration-of-medical-claims-data2026-08-18https://www.concertai.com/blog/lightning-strikes-ai-and-the-fda-elsa-goes-live-and-ai-gains-common-sensehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20AI%20and%20the%20FDA%20Pt2.pngConcertAI Blog - AI and the FDA Pt2ConcertAI Blog - AI and the FDA Pt2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-06-09https://www.concertai.com/publications/seizure-related-6-homolog-sez6-expression-pattern-and-prognostic-impact-in-a-real-world-cohort-of-patients-with-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/2024/03/machine-learning-imputation-of-eastern-cooperative-oncology-group-performance-status-ecog-ps-scores-from-data-in-cancerlinq-discovery/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/datavant-health-data-summit/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/People-Customer-Centric-Employees.svgPeople-Customer-Centric-EmployeesPeople-Customer-Centric-Employeeshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Data-Unsupervised-Learning-Variable-Diversity.svgData-Unsupervised-Learning-Variable-DiversityData-Unsupervised-Learning-Variable-Diversityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AI-RWE-Insights-Innovation.svgAI-RWE-Insights-InnovationAI-RWE-Insights-Innovationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Global-Search-Magnify.svgGlobal-Search-MagnifyGlobal-Search-Magnifyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Jeff-Datavant-Quote-v3-01.pngJeff-Datavant-Quote-v3-01Jeff-Datavant-Quote-v3-01https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient-Study-Data-Predictive.svgPatient-Study-Data-PredictivePatient-Study-Data-Predictivehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DSC06077-1-scaled.jpgDSC06077-1-scaledDSC06077-1-scaled2024-04-02https://www.concertai.com/publications/pediatric-cancer-in-the-united-states-a-comparison-of-two-data-sources2026-08-18https://www.concertai.com/trial-optimization_burden-analysishttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Jamie-Powers.pngJamie-PowersJamie-Powershttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eurekaClinical-Webinar.pngeurekaClinical-WebinareurekaClinical-Webinar2024-03-29https://www.concertai.com/publications/improving-real-world-mortality-data-quality-in-oncology-research-augmenting-electronic-medical-records-with-obituary-social-security-death-index-and-commercial-claims2026-08-18https://www.concertai.com/publications/real-world-response-endpoints-in-patients-with-mnsclc-treated-with-chemotherapy-across-real-world-datasets2026-08-18https://www.concertai.com/publications/2024/03/real-world-characteristics-and-outcomes-among-patients-with-advanced-non-small-cell-lung-cancer-ansclc-receiving-immune-checkpoint-inhibitorshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/2024/03/real-world-outcomes-of-cancerlinq-patients-with-advanced-non-small-cell-lung-cancerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/survival-outcomes-of-cabazitaxel-or-subsequent-androgen-receptor-pathway-inhibitor-arpi-in-post-docetaxel-arpi-metastatic-castration-resistant-prostate-cancer2026-08-18https://www.concertai.com/blog/2023/03/the-concertai-podcast-revolutionizing-medical-imaging-using-ai-feat-terarecons-dan-mcsweeneyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/IMG_8175-2-1024x768-1.jpgIMG_8175-2-1024x768-1IMG_8175-2-1024x768-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM.pngConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Screen-Shot-2023-03-27-at-9_12_20-AM-1024x576-1.jpgScreen-Shot-2023-03-27-at-9_12_20-AM-1024x576-1Screen-Shot-2023-03-27-at-9_12_20-AM-1024x576-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-17https://www.concertai.com/publications/real-world-comparative-effectiveness-in-advanced-nsclc-and-high-pd-l1-with-1l-immune-checkpoint-inhibitors-plus-minus-chemotherapy2026-08-18https://www.concertai.com/publications/utilization-of-liquid-biopsy-in-metastatic-castrate-resistant-prostate-cancer-mcrpc-patient-characteristics-treatment-selection-and-mutational-status2026-08-18https://www.concertai.com/support-pagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Intro%20Splash%20Original%202.gifConcertAI Intro Splash Original 2ConcertAI Intro Splash Original 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Imaging%20Solutions%20Social%20SQ%20(1).pngTeraRecon Imaging Solutions Social SQ (1)TeraRecon Imaging Solutions Social SQ (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_8https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CLQ%20Social%20SQ.pngCLQ Social SQCLQ Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Social%20SQ%20(1).pngConcertAI Social SQ (1)ConcertAI Social SQ (1)2026-05-27https://www.concertai.com/events_oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SCCT%202026%20Graphic.pngSCCT 2026 GraphicSCCT 2026 Graphichttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ESMO%202026.pngESMO 2026ESMO 2026https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RSNA%202026-2.pngRSNA 2026-2RSNA 2026-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2026-05-28https://www.concertai.com/publications/population-based-trends-and-outcomes-for-cytoreductive-nephrectomy-for-metastatic-renal-cell-carcinoma-in-the-united-states2026-08-18https://www.concertai.com/commercial-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Social%20SQ%20(2).pngPrecision360 Social SQ (2)Precision360 Social SQ (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Screengrab%201.pngSpecialty Data Screengrab 1Specialty Data Screengrab 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Commercial%20Solutions%20Banner.pngCommercial Solutions BannerCommercial Solutions Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PrecisionGTM.pngPrecisionGTMPrecisionGTMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Efficiency%202.svgEfficiency 2Efficiency 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Intelligence%202.svgIntelligence 2Intelligence 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Acceleration.svgAccelerationAccelerationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Specialty%20Data%20Social%20SQ.pngSpecialty Data Social SQSpecialty Data Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cadence%20Suite%20Social%20SQ.pngCadence Suite Social SQCadence Suite Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Visibility.svgVisibilityVisibilityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Commercial%20Solutions%20Homepage%20Image%202025.pngCommercial Solutions Homepage Image 2025Commercial Solutions Homepage Image 2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/screencapture-cadence-demo-concertai-market-intelligence-2026-04-17-15_11_07.pngscreencapture-cadence-demo-concertai-market-intelligence-2026-04-17-15_11_07screencapture-cadence-demo-concertai-market-intelligence-2026-04-17-15_11_072026-04-21https://www.concertai.com/case-study-resolving-systemic-product-accesshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Resolving-Systemic-Access-Issues_Snip-for-Download-form.pngResolving-Systemic-Access-Issues_Snip-for-Download-formResolving-Systemic-Access-Issues_Snip-for-Download-form2024-04-01https://www.concertai.com/publications/2024/03/health-resource-utilization-and-costs-in-brca-positive-metastatic-breast-cancer-patients-treated-in-the-community-oncology-setting/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/news/2023/11/concertai-announces-agreement-with-leading-cancer-center-to-accelerate-and-transform-precision-oncology-through-ai-enabled-imaging-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-13-3-1024x1024.pngArtboard-1-copy-13-3-1024x1024Artboard-1-copy-13-3-1024x1024https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-06https://www.concertai.com/publications/association-of-mrna-covid-19-vaccination-near-immune-checkpoint-inhibitor-initiation-with-outcomes-a-real-world-analysis2026-08-18https://www.concertai.com/publications/identifying-the-genetic-basis-for-resistance-to-aromatase-inhibitors-ais-in-metastatic-breast-cancer-mbc-patients2026-08-18https://www.concertai.com/publications/predicting-progression-free-survival-pfs-in-first-line-1l-immune-checkpoint-inhibitor-ici-treated-patients-pts-with-advanced-non-small-cell-lung-cancer-ansclc-machine2026-08-18https://www.concertai.com/publications/2024/03/patient-reported-outcomes-among-those-taking-pazopanib-for-metastatic-renal-cell-carcinoma-mrcc-in-a-community-oncology-setting/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/evolution-in-oncology-healthcarehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-32-2-2048x513.pngArtboard-1-copy-32-2-2048x513Artboard-1-copy-32-2-2048x5132024-04-02https://www.concertai.com/publications/a-retrospective-analysis-of-treatment-patterns-overall-survival-and-real-world-disease-free-survival-in-early-stage-non-small-cell-lung-cancer-following-complete2026-08-18https://www.concertai.com/blog/cus-healthcare-system-deploys-ai-agents-from-research-to-roundshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/2024%20CAI%20ASCO%20-%20Rectangle%20(2).png2024 CAI ASCO - Rectangle (2)2024 CAI ASCO - Rectangle (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-10-08https://www.concertai.com/resource-hubhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_2-1.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_2-1CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_2-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-05-27https://www.concertai.com/webinar_4_20_addressing_health_disparities-in-trial-designhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Webinar_4_20_Addressing-Health-Disparities_Social_Updated-Title.jpgWebinar_4_20_Addressing-Health-Disparities_Social_Updated-TitleWebinar_4_20_Addressing-Health-Disparities_Social_Updated-Titlehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Jennifer-Rider_Circle.jpgJennifer-Rider_CircleJennifer-Rider_Circle2024-03-29https://www.concertai.com/on-demand-eca-webinar-q9w8erqwedasdhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/icon-play.svgicon-playicon-playhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Screen-Shot-2020-10-07-at-11.53.32-AM.pngScreen-Shot-2020-10-07-at-11.53.32-AMScreen-Shot-2020-10-07-at-11.53.32-AMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/blog/concertai-appoints-james-salitan-as-general-counselhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/James%20Salitan%20PR.pngJames Salitan PRJames Salitan PR2024-10-01https://www.concertai.com/terarecon-neurohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_9.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_9CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_9https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/neuro.pngneuroneuro2026-06-10https://www.concertai.com/publications/real-world-monotherapy-and-combination-usage-of-mogamulizumab-among-patients-with-mycosis-fungoides-or-sezary-syndrome-in-the-united-states2026-08-18https://www.concertai.com/events/evolution-in-oncology-care-feat-george-w-sledge-phd/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/publications/real-world-patient-characteristics-and-treatment-patterns-among-cholangiocarcinoma-patients-treated-with-fgfr-inhibitors2026-08-18https://www.concertai.com/publications/real-world-frontline-treatments-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-epidermal-growth-factor-receptor-exon-20-insertions-and-adjusted2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-outcomes-of-patients-with-metastatic-nonsquamous-non-small-cell-lung-cancer-after-progression-on-standard-of-care-therapy-in-the2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-survival-in-people-with-metastatic-castration-resistant-prostate-cancer-following-metastatic-hormone-sensitive-disease-between-20202026-08-18https://www.concertai.com/publications/machine-learning-ml-model-for-prediction-of-pneumonitis-using-real-world-data-rwd-on-immune-checkpoint-inhibitor-ici-treated-advanced-non-small-cell-lung-cancer-ansclc2026-08-18https://www.concertai.com/publications/comparison-of-dna-sequencing-immunohistochemistry-and-in-situ-hybridization-techniques-to-determine-her2-status-in-metastatic-breast-cancer-patients2026-08-18https://www.concertai.com/publications/characteristics-of-real-world-rw-natalee-and-monarche-eligible-populations-a-us-electronic-health-records-ehr-database-analysis2026-08-18https://www.concertai.com/news/2024/01/concertai-and-caris-life-sciences-announce-strategic-agreement-with-abbvie-to-accelerate-oncology-pipeline-and-clinical-trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Abbvie-Announcement.pngAbbvie-AnnouncementAbbvie-Announcementhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-06https://www.concertai.com/publications/2024/03/characteristics-of-patients-receiving-immune-checkpoint-inhibitors-ici-in-asco-cancerlinqs-discovery-database/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/comparing-traditional-nlp-methods-and-llm-based-extraction-for-identifying-biomarkers-in-lung-cancer2026-08-18https://www.concertai.com/publications/picturing-progression-a-new-role-of-whole-slide-imaging-in-comprehensive-clinical-genomic-datasets2026-08-18https://www.concertai.com/blog/2023/12/the-next-horizon-concertai-and-cancerlinqhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/The-Next-Horizon-ConcertAI-and-CancerLinQ-1.pngThe-Next-Horizon-ConcertAI-and-CancerLinQ-1The-Next-Horizon-ConcertAI-and-CancerLinQ-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-30-1024x256-1.pngArtboard-1-copy-30-1024x256-1Artboard-1-copy-30-1024x256-12024-03-17https://www.concertai.com/publications/variation-in-genomic-testing-amongst-localized-prostate-cancer-patients-undergoing-radical-prostatectomy-or-radiation-therapy-results-from-a-population-based2026-08-18https://www.concertai.com/news/concertai-announces-cloud-based-saas-transformation-of-terarecon-portfoliohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/RSNA%202024%20Socials%20(1)-1.pngRSNA 2024 Socials (1)-1RSNA 2024 Socials (1)-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-12-03https://www.concertai.com/publications/real-world-treatment-tx-patterns-in-patients-pts-with-hr-plus-her2-metastatic-breast-cancer-mbc-treated-with-chemotherapy-ct-in-the-united-states-us2026-08-18https://www.concertai.com/dts-for-sponsors-factsheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DTS%20Sponsors%20Cover.jpgDTS Sponsors CoverDTS Sponsors Cover2024-05-22https://www.concertai.com/publications/treatment-patterns-overall-survival-os-and-disease-free-survival-dfs-in-early-stage-non-small-cell-lung-cancer-nsclc-following-complete-resection2026-08-18https://www.concertai.com/publications/practice-patterns-and-outcomes-of-conventional-versus-split-dose-cisplatin-in-neoadjuvant-ddmvac-in-bladder-cancer2026-08-18https://www.concertai.com/publications/adverse-events-and-clinical-outcomes-in-patients-treated-with-pd-l-1-blockade-for-advanced-non-small-cell-lung-cancer2026-08-18https://www.concertai.com/publications/quantification-of-information-gained-by-linking-claims-data-to-an-ehr-cohort-of-us-metastatic-breast-cancer-mbc-patients2026-08-18https://www.concertai.com/news/the-definitive-guide-to-artificial-intelligence-predictions-for-2025-0-0https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20-%20SR%20.pngConcertAI Press Release - SR ConcertAI Press Release - SR https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-03-26https://www.concertai.com/events/first-in-class-ai-jit-and-rwe-for-clinical-development/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubled2024-03-26https://www.concertai.com/publications/real-world-prostate-specific-antigen-psa-response-with-darolutamide-or-abiraterone-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-triplet-therapy2026-08-18https://www.concertai.com/patient-matchinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Transparency.pngTransparencyTransparencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/inclusion_1.svginclusion_1inclusion_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/speed_2.svgspeed_2speed_2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20Banner.pngPatient Matching BannerPatient Matching Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20Image.pngPatient Matching ImagePatient Matching Imagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/compliance_1.svgcompliance_1compliance_1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20(NEW).pngPatient Matching (NEW)Patient Matching (NEW)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/efficiency.svgefficiencyefficiencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Patient%20Matching%20Social%20SQ.pngPatient Matching Social SQPatient Matching Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Operational%20Dash.pngOperational DashOperational Dash2025-09-25https://www.concertai.com/publications/recurrence-and-its-association-with-overall-survival-os-in-muscle-invasive-bladder-cancer-mibc-patients-undergoing-radical-cystectomy-rc-a-real-world-analysis2026-08-18https://www.concertai.com/publications/identification-of-predictive-subphenotypes-for-clinical-outcomes-using-real-world-data-and-machine-learning2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-outcomes-in-patients-with-hr-plus-her2-metastatic-breast-cancer-treated-with-chemotherapy-in-the-united-states2026-08-18https://www.concertai.com/publications/calibrating-observational-health-record-data-against-a-randomized-trial2026-08-18https://www.concertai.com/publications/oncology-trial-emulation-using-real-world-electronic-health-record-data-results-of-the-coalition-to-advance-real-world-evidence-through-randomized-controlled-trial2026-08-18https://www.concertai.com/publications/survival-in-the-real-world-a-national-analysis-of-patients-treated-for-early-stage-breast-cancer2026-08-18https://www.concertai.com/news/2023/02/seungtaek-lee-named-concertais-vice-president-of-strategic-provider-partnershipshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Seungtaek-Lee-VP-of-Strategic-Provider-Partnerships-Announcement.pngSeungtaek-Lee-VP-of-Strategic-Provider-Partnerships-AnnouncementSeungtaek-Lee-VP-of-Strategic-Provider-Partnerships-Announcementhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-06https://www.concertai.com/prometricshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/hero-img-prometrics.jpghero-img-prometricshero-img-prometricshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/gif/Patient-Journey-Animated-wText.gifPatient-Journey-Animated-wTextPatient-Journey-Animated-wText2024-07-08https://www.concertai.com/publications/real-world-study-on-the-characteristics-post-nephrectomy-journey-and-outcomes-of-patients-with-early-stage-renal-cell-carcinoma-based-on-risk-groups2026-08-18https://www.concertai.com/news/asco-2024-study-indicates-multi-ai-model-scalability-key-in-streamlining-of-clinical-trial-site-selection-processhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20PR%20Poster%20-%20Multi-AI%20model%20(1).pngASCO PR Poster - Multi-AI model (1)ASCO PR Poster - Multi-AI model (1)2024-05-30https://www.concertai.com/life-sciences-and-pharmahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_9.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_9CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_9https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Explorer%20V1-3.pngPrecision Explorer V1-3Precision Explorer V1-3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Clinical%20Trials%20Cover-2.pngConcertAI Clinical Trials Cover-2ConcertAI Clinical Trials Cover-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amgen%20Logo%20White.svgAmgen Logo WhiteAmgen Logo Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Astellas%20White.svgAstellas WhiteAstellas Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Commercial%20(1).pngConcertAI Commercial (1)ConcertAI Commercial (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/abbvie.svgabbvieabbviehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AstraZeneca.svgAstraZenecaAstraZenecahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Merck%20(White).svgMerck (White)Merck (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Otsuka_Holdings_logo%20(White).svgOtsuka_Holdings_logo (White)Otsuka_Holdings_logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Regeneron.svgRegeneronRegeneronhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Lilly%20Logo%20(White).svgLilly Logo (White)Lilly Logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Life%20Sciences%20&%20Pharma.pngLife Sciences & PharmaLife Sciences & Pharma2026-05-27https://www.concertai.com/blog/2023/01/the-concertai-podcast-multi-modal-data-feat-claudio-dambrosiohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Jeff-Claudio-Podcast-Session-1.jpgJeff-Claudio-Podcast-Session-1Jeff-Claudio-Podcast-Session-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM.pngConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/IMG_8291-2-2-1.jpgIMG_8291-2-2-1IMG_8291-2-2-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PM.pngConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PMConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/IMG_8272-2-1.jpgIMG_8272-2-1IMG_8272-2-12024-03-17https://www.concertai.com/ispor2023https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-ISPOR-BG.pngConcertAI-ISPOR-BGConcertAI-ISPOR-BGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet.svgMeetMeethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-ISPOR.pngConcertAI-ISPORConcertAI-ISPORhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-@-ISPOR-SVG-Logo.svgConcertAI-@-ISPOR-SVG-LogoConcertAI-@-ISPOR-SVG-Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ISPOR-2023-2-Weeks.pngISPOR-2023-2-WeeksISPOR-2023-2-Weeks2024-04-03https://www.concertai.com/asco2023-posters-form/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/View%20ConcertAI%E2%80%99s%20ASCO%202023%20Posters.pngView ConcertAI’s ASCO 2023 PostersView ConcertAI’s ASCO 2023 Postershttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/news/2023/10/concertai-ranked-12-on-the-healthcare-technology-reports-the-top-100-healthcare-technology-companies-of-2023https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-19@2x-1024x536.pngArtboard-1-copy-19@2x-1024x536Artboard-1-copy-19@2x-1024x536https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-06https://www.concertai.com/news/concertai-appoints-dr.-shaalan-beg-as-chief-medical-officer-oncologyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Shaalan%20Beg%20PR.pngShaalan Beg PRShaalan Beg PRhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-10-22https://www.concertai.com/publications/2024/03/identifying-non-small-cell-lung-cancer-patients-from-a-cohort-of-heterogeneous-lung-cancer-patients-using-boosted-trees-on-electronic-health-records-data/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/use-of-immunosuppressive-drugs-and-the-effectiveness-of-immune-checkpoint-inhibitor-therapy-among-patients-with-advanced-metastatic-non-small-cell-lung-cancer-in-the2026-08-18https://www.concertai.com/publications/overall-survival-after-treatment-with-first-line-osimertinib-for-egfr-mutant-advanced-nsclc-in-the-us2026-08-18https://www.concertai.com/publications/a-multi-agent-ai-system-integrating-real-world-data-and-competitive-intelligence-to-generate-automated-trial-eligibility-recommendations2026-08-18https://www.concertai.com/blog-example/lighting-strikes-the-paradigm-shift-in-regulatory-ai-clonehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-12025-05-28https://www.concertai.com/publications/correlation-of-intermediate-clinical-endpoints-ices-for-overall-survival-os-in-localized-or-locally-advanced-prostate-cancer-lpc-lapc-analysis-of-individual-real2026-08-18https://www.concertai.com/publications/2024/03/using-an-epro-tool-to-help-meet-quality-metrics-in-a-clinical-oncology-practice/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/prognostic-score-models-for-acquired-resistance-to-frontline-anti-programmed-cell-death-protein-1-programmed-death-ligand-1-therapy-in-metastatic-non-small-cell-lung2026-08-18https://www.concertai.com/researchhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Gradient-1-1260x560-1.jpgGradient-1-1260x560-1Gradient-1-1260x560-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/hero-img-contact-us@1.5x.jpghero-img-contact-us@1.5xhero-img-contact-us@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Gradient-3-1260x560-1.jpgGradient-3-1260x560-1Gradient-3-1260x560-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/news/2024/01/concertai-adds-healthtech-leader-as-senior-vice-president-and-general-manager-of-digital-trial-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Ryan-Kennedy-PR-1.pngRyan-Kennedy-PR-1Ryan-Kennedy-PR-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-04-01https://www.concertai.com/publications/biomarker-testing-and-patterns-of-treatment-in-nsclc-patients-an-iaslc-analysis-of-asco-cancerlinq-discovery-data2026-08-18https://www.concertai.com/publications/treatment-intensification-in-metastatic-hormone-sensitive-prostate-cancer-an-analysis-of-real-world-practice-patterns-from-the-cancerlinq-database2026-08-18https://www.concertai.com/blog/concertai-at-asco-2026-precision360-weekly-curation-powers-new-possibilityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-07-15https://www.concertai.com/publications/treatment-outcomes-in-patients-pts-with-advanced-metastatic-nonsmall-cell-lung-cancer-nsclc-harboring-met-amplification-as-a-secondary-oncogenic-driver2026-08-18https://www.concertai.com/concertai-at-qcca-fall-2022/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us.svgMeet-With-UsMeet-With-Ushttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Asset.svgAssetAssethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/QCCA.pngQCCAQCCAhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Concertai%20QCCA.pngConcertai QCCAConcertai QCCAhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-03https://www.concertai.com/commercialhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-Commercial%20-V2.mp4/medium.jpgCAI-BGLoop-Commercial -V2CAI-BGLoop-Commercial -V2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-Commercial%20-V2.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai_-_cadence_suite_(subs)_v4%20(2160p).mp4/medium.jpgconcertai_-_cadence_suite_(subs)_v4 (2160p)concertai_-_cadence_suite_(subs)_v4 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai_-_cadence_suite_(subs)_v4%20(2160p).mp4194nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Astellas%20White.svgAstellas WhiteAstellas Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Merck%20(White).svgMerck (White)Merck (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CADENCE%20SUITE.pngCADENCE SUITECADENCE SUITEhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DATA%20FOUNDRY%20IMG.pngDATA FOUNDRY IMGDATA FOUNDRY IMGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Lilly%20Logo%20(White).svgLilly Logo (White)Lilly Logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Regeneron.svgRegeneronRegeneronhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Image%201.pngPrecision360 Image 1Precision360 Image 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20GTM%20IMG.pngPrecision GTM IMGPrecision GTM IMGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AstraZeneca.svgAstraZenecaAstraZenecahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amgen%20Logo%20White.svgAmgen Logo WhiteAmgen Logo Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Otsuka_Holdings_logo%20(White).svgOtsuka_Holdings_logo (White)Otsuka_Holdings_logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/abbvie.svgabbvieabbviehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Commercial%20(1).pngConcertAI Commercial (1)ConcertAI Commercial (1)2026-05-28https://www.concertai.com/publications/efficacy-of-lurbinectedin-in-a-clinical-trial-versus-standard-of-care-in-a-real-world-comparator-arm-in-relapsed-refractory-small-cell-lung-cancer-patients2026-08-18https://www.concertai.com/news/exigent-research-leading-national-community-research-network-partners-with-ai-leader-concertai-to-integrate-caraai-precision-trial-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20with%20Exigent%20CARAai%20(1).pngConcertAI Press Release with Exigent CARAai (1)ConcertAI Press Release with Exigent CARAai (1)2025-02-03https://www.concertai.com/trialinqhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TriaLinQ%20Banner.pngTriaLinQ BannerTriaLinQ Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2021.svgAsset 21Asset 21https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TriaLinQ%20Cover.pngTriaLinQ CoverTriaLinQ Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/reduced%20site%20burden.svgreduced site burdenreduced site burdenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TriaLinQ%20Suite%20Social%20SQ.pngTriaLinQ Suite Social SQTriaLinQ Suite Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Asset%2017.svgAsset 17Asset 17https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/expanded%20access_1.svgexpanded access_1expanded access_12025-05-30https://www.concertai.com/publications/androgen-receptor-pathway-inhibitors-triplet-therapy-araat-real-world-outcomes-in-metastatic-hormone-sensitive-prostate-cancer2026-08-18https://www.concertai.com/publications/pitfalls-with-analyses-of-real-world-data-a-look-at-ascos-cancerlinq-discovery-multiple-myeloma-dataset2026-08-18https://www.concertai.com/terms-of-usehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logo2025-06-30https://www.concertai.com/publications/emulations-of-oncology-trials-using-real-world-data-a-systematic-literature-review2026-08-18https://www.concertai.com/publications/chart-review-study-on-dose-modifications-of-patients-with-myelodysplastic-syndrome-treated-with-hypomethylating-agents2026-08-18https://www.concertai.com/regulatory-usehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/hero-img-regulatory-use@1.5x.jpghero-img-regulatory-use@1.5xhero-img-regulatory-use@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ico-regulatory.svgico-regulatoryico-regulatoryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ico_find-patients.svgico_find-patientsico_find-patientshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ico_customized-datasets.svgico_customized-datasetsico_customized-datasets2024-04-02https://www.concertai.com/publications/clinical-use-and-outcomes-of-androgen-receptor-pathway-inhibitors-triplet-therapy-for-metastatic-hormone-sensitive-prostate-cancer-araat2026-08-18https://www.concertai.com/publications/psa-nadir-stratified-outcomes-of-arpi-doublet-and-docetaxel-triplet-therapy-in-metastatic-prostate-cancer2026-08-18https://www.concertai.com/publications/correlation-analysis-of-invasive-disease-free-survival-and-overall-survival-in-a-real-world-population-of-patients-with-hr-plus-her2-early-breast-cancer2026-08-18https://www.concertai.com/blog/an-imperative-redoubled-taking-care-of-more-cancer-patients-with-fewer-oncologistshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-02-05https://www.concertai.com/publications/machine-learning-modeling-of-real-world-primary-resistance-and-hyperprogression-in-immune-checkpoint-inhibitor-ici-treated-advanced-non-small-cell-lung-cancer-ansclc2026-08-18https://www.concertai.com/publications/overall-survival-in-egfr-mutant-advanced-nsclc-treated-with-first-line-osimertinib-a-cohort-study-integrating-clinical-and-biomarker-data-in-the-united-states2026-08-18https://www.concertai.com/publications/real-world-treatment-options-for-metastatic-nsclc-patients-following-progression-on-chemo-immunotherapy2026-08-18https://www.concertai.com/precision360https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Image%201.pngPrecision360 Image 1Precision360 Image 1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_10.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_10CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Overall_10https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-07-14https://www.concertai.com/concertai-asco-publications-2022https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Presentations-Race-Differences.jpgPresentations-Race-DifferencesPresentations-Race-Differenceshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Ocean-Blu-2048x1152.jpgPublications-Ocean-Blu-2048x1152Publications-Ocean-Blu-2048x1152https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Blurple.jpgPublications-BlurplePublications-Blurplehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Presentations-Impact-of-Trial.jpgPresentations-Impact-of-TrialPresentations-Impact-of-Trialhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Asset-6.svgAsset-6Asset-6https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Purple.jpgPublications-PurplePublications-Purplehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Pool-Blue.jpgPublications-Pool-BluePublications-Pool-Bluehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Presentations-Natural-Language.jpgPresentations-Natural-LanguagePresentations-Natural-Languagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Presentations-Identifying-Genetic.jpgPresentations-Identifying-GeneticPresentations-Identifying-Genetic2024-04-01https://www.concertai.com/publications/clinical-outcomes-among-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc-who-received-immune-checkpoint-inhibitors-ici-in-first-1l-and-second-line-2l2026-08-18https://www.concertai.com/publications/digital-trial-solutions-escreening-software-to-rank-patients-by-their-predicted-clinical-trial-eligibility-using-real-world-data-and-machine-learning2026-08-18https://www.concertai.com/publications/real-world-clinical-outcomes-of-patients-pts-with-metastatic-colorectal-cancer-mcrc-who-received-trifluridine-tipiracil-ftd-tpi-monotherapy-or-ftd-tpi-plus-bevacizumab2026-08-18https://www.concertai.com/publications/trifluridine-tipiracil-with-and-without-bevacizumab-in-colorectal-cancer2026-08-18https://www.concertai.com/publications/integrating-real-world-histopathological-and-clinicogenomic-data-from-1799-lung-cancer-patients-by-applying-unsupervised-deep-learning2026-08-18https://www.concertai.com/publications/harmonizing-logical-observation-identifiers-names-and-codes-loinc-codes-and-units-in-real-world-oncology-data-method-development-and-evaluation2026-08-18https://www.concertai.com/imaging-workflowshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TeraRecon%20Detect/DETECT%20coronary%20workflow%2016%20x%209.pngDETECT coronary workflow 16 x 9DETECT coronary workflow 16 x 9https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6-1.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6-1CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_EnterpriseImaging_6-12026-07-27https://www.concertai.com/events/ecr-2024/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/blog/we-know-lung-cancer-screening-saves-lives-how-can-we-assure-accesshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/We%20Know%20Lung%20Cancer%20Screening%20Saves%20Lives%20How%20Can%20We%20Assure%20Access.pngWe Know Lung Cancer Screening Saves Lives How Can We Assure AccessWe Know Lung Cancer Screening Saves Lives How Can We Assure Access2024-05-09https://www.concertai.com/news/2024-asco-annual-meeting-study-demonstrates-that-ai-models-for-predicting-patient-availability-for-clinical-trials-showed-a-2-4x-improvement-over-traditional-approacheshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ASCO%20PR%20Poster%20-%202-4x%20times-1.pngASCO PR Poster - 2-4x times-1ASCO PR Poster - 2-4x times-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-06-04https://www.concertai.com/news/concertai-presents-at-the-morgan-stanley-22nd-annual-global-healthcare-conferencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/1Artboard%2035.png1Artboard 351Artboard 352024-09-05https://www.concertai.com/publications/representativeness-of-race-ethnicity-and-social-determinants-of-health-in-patients-with-advanced-non-small-cell-lung-cancer-via-linkage-of-real-world-electronic-health2026-08-18https://www.concertai.com/exigent-concertai-jithttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-27https://www.concertai.com/publications/incidence-of-severe-acute-respiratory-syndrome-coronavirus-2-and-subsequent-mortality-in-a-multisite-cohort-of-patients-with-cancer-in-the-cancerlinq-discovery-database2026-08-18https://www.concertai.com/publications/impact-of-real-world-treatment-sequencing-patterns-on-time-to-next-treatment-among-patients-with-chronic-lymphocytic-leukemia-in-the-united-states2026-08-18https://www.concertai.com/publications/mortality-among-egfr-mutated-advanced-nsclc-patients-after-frontline-osimertinib-treatment-a-real-world-us-attrition-analysis2026-08-18https://www.concertai.com/publications/folate-receptor-alpha-fr-alpha-folr1-expression-and-persistence-in-ovarian-cancer-in-clinical-trial-samples-and-real-world-patient-cohort2026-08-18https://www.concertai.com/concertai-at-ash-2022https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/People-Customer-Centric-Employees.svgPeople-Customer-Centric-EmployeesPeople-Customer-Centric-Employeeshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Pool-Blue-scaled.jpgPublications-Pool-Blue-scaledPublications-Pool-Blue-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Purple-scaled.jpgPublications-Purple-scaledPublications-Purple-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Computer-Data-Chart-Research.svgComputer-Data-Chart-ResearchComputer-Data-Chart-Researchhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Academic-Center.svgAcademic-CenterAcademic-Centerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us-1.svgMeet-With-Us-1Meet-With-Us-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/AI-EurekaAI-Mind-Person.svgAI-EurekaAI-Mind-PersonAI-EurekaAI-Mind-Personhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-at-ASH-Banner.pngConcertAI-at-ASH-BannerConcertAI-at-ASH-Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ASH-BG-Banner-Only.pngASH-BG-Banner-OnlyASH-BG-Banner-Onlyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Linked-Claims-Assemble.svgLinked-Claims-AssembleLinked-Claims-Assemblehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Publications-Blurple-scaled.jpgPublications-Blurple-scaledPublications-Blurple-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-03https://www.concertai.com/eca-infographichttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA-infograph.svgECA-infographECA-infographhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-29https://www.concertai.com/publications/an-emulation-of-the-keynote-189-trial-using-electronic-health-records2026-08-18https://www.concertai.com/publications/real-world-clinical-outcomes-in-patients-pts-with-hr-plus-her2-metastatic-breast-cancer-mbc-treated-with-chemotherapy-ct-in-the-united-states-us2026-08-18https://www.concertai.com/publications/the-resect-study-factors-associated-with-overall-survival-os-and-relapse-free-survival-rfs-among-patients-with-stages-i-iii-resected-nsclc-without-known-egfr-mutations2026-08-18https://www.concertai.com/accelerated-clinical-trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20Video%20v2.mp4/medium.jpgACT Video v2ACT Video v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20Video%20v2.mp4174nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/D01_ConcertAI-Frost-Radar-020426.pngD01_ConcertAI-Frost-Radar-020426D01_ConcertAI-Frost-Radar-020426https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20White%20Paper%20Render.pngACT White Paper RenderACT White Paper Renderhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_ClinicalTrials_5.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_ClinicalTrials_5CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_ClinicalTrials_5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20COHORT%20CREATION-2.pngACT COHORT CREATION-2ACT COHORT CREATION-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20-%20Site%20Selection%20Optimization-3.pngACT - Site Selection Optimization-3ACT - Site Selection Optimization-3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT.pngACTACThttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ACT%20-%20Study%20Design%20Optimization-2-1.pngACT - Study Design Optimization-2-1ACT - Study Design Optimization-2-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_ClinicalTrials_3.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_ClinicalTrials_3CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_ClinicalTrials_3https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Trial%20Health.pngTrial HealthTrial Health2026-06-03https://www.concertai.com/publications/real-world-evidence-shows-no-survival-advantage-with-contemporary-first-line-strategies-in-papillary-renal-cell-carcinoma-a-call-for-randomized-trials2026-08-18https://www.concertai.com/news/radnets-wholly-owned-subsidiary-deephealth-and-concertais-terarecon-announce-strategic-collaboration-around-integrated-ai-and-advanced-visualizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20TR%20and%20DeepHealth.pngConcertAI Press Release TR and DeepHealthConcertAI Press Release TR and DeepHealthhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-02-25https://www.concertai.com/publications/variation-of-hormonal-agent-usage-with-postoperative-radiation-therapy-results-from-a-population-based-cohort-of-prostate-cancer-patients-in-community-oncology-practices2026-08-18https://www.concertai.com/publications/emulating-comparative-oncology-trials-with-real-world-evidence-studies-encore-process-development-and-methodological-considerations-for-oncology-real-world-data2026-08-18https://www.concertai.com/enterprise-imaginghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-03-ImagingWorkflows.mp4/medium.jpgCAI-BGLoop-03-ImagingWorkflowsCAI-BGLoop-03-ImagingWorkflowshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop-03-ImagingWorkflows.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Enterprise%20Imaging%20(TeraRecon)%20(1).pngConcertAI Enterprise Imaging (TeraRecon) (1)ConcertAI Enterprise Imaging (TeraRecon) (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/TR%20Multi%20Pronged.png-1.pngTR Multi Pronged.png-1TR Multi Pronged.png-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/image-png-Nov-05-2025-09-37-48-7888-PM.pngimage-png-Nov-05-2025-09-37-48-7888-PMimage-png-Nov-05-2025-09-37-48-7888-PM2026-07-27https://www.concertai.com/publications/post-metastasis-survival-in-high-risk-localised-and-locally-advanced-prostate-cancer-patients-undergoing-primary-treatment-in-the-united-states-a-retrospective-study2026-08-18https://www.concertai.com/publications/risk-of-death-before-and-after-metastasis-in-high-risk-localized-and-locally-advanced-prostate-cancer-patients-undergoing-radical-prostatectomy-or-radiotherapy-as2026-08-18https://www.concertai.com/request-a-dts-demo/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions.jpgDigital Trial SolutionsDigital Trial Solutions2024-03-27https://www.concertai.com/publications/real-world-study-characterizing-patient-characteristics-treatments-and-unmet-need-in-io-ineligible-patients-with-metastatic-triple-negative-breast-cancer2026-08-18https://www.concertai.com/news/the-definitive-guide-to-artificial-intelligence-predictions-for-2025https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20-%20SR%20.pngConcertAI Press Release - SR ConcertAI Press Release - SR https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2025-01-24https://www.concertai.com/news/2023/04/concertai-releases-cto-2-0https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/whyClinicalTrialsWillNeverBeTheSame-1-1024x1024.pngwhyClinicalTrialsWillNeverBeTheSame-1-1024x1024whyClinicalTrialsWillNeverBeTheSame-1-1024x1024https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-38-copy.pngArtboard-38-copyArtboard-38-copy2024-03-06https://www.concertai.com/publications/adjusted-comparison-of-amivantamab-in-combination-with-carboplatin-plus-pemetrexed-from-the-papillon-study-versus-us-real-world-frontline-treatments-in-patients2026-08-18https://www.concertai.com/publications/post-metastasis-survival-of-patients-with-high-risk-localized-and-locally-advanced-prostate-cancer-undergoing-primary-treatment-in-the-united-states-a-retrospective-study2026-08-18https://www.concertai.com/caraaihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/faster%20insights.svgfaster insightsfaster insightshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/real%20world%20ready.svgreal world readyreal world readyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Social%20SQ%20v2.pngCARAai Social SQ v2CARAai Social SQ v2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Banner.pngCARAai BannerCARAai Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Reliable%20Insights-1.pngCARAai Reliable Insights-1CARAai Reliable Insights-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Reliable%20Insights%20(2)-1.pngCARAai Reliable Insights (2)-1CARAai Reliable Insights (2)-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/fully%20embedded.svgfully embeddedfully embeddedhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/deeper%20understanding.svgdeeper understandingdeeper understandinghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Layer%20Cake%20v2-1.pngCARAai Layer Cake v2-1CARAai Layer Cake v2-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CARAai%20Smarter%20Data-1.pngCARAai Smarter Data-1CARAai Smarter Data-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/dtv%20(18).jpgdtv (18)dtv (18)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cara%20Social%20SQ%20v2.pngCara Social SQ v2Cara Social SQ v22026-04-21https://www.concertai.com/news/concertai-appoints-missy-jerome-as-chief-people-officerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Social/Missy%20Jerome%20PR%20(1).pngMissy Jerome PR (1)Missy Jerome PR (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-03-27https://www.concertai.com/asco2023/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-13@2x-2048x2048.pngArtboard-1-copy-13@2x-2048x2048Artboard-1-copy-13@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-4@2x2.pngArtboard-1-copy-4@2x2Artboard-1-copy-4@2x2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-7@2x-2048x2048.pngArtboard-1-copy-7@2x-2048x2048Artboard-1-copy-7@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1@2x2.pngArtboard-1@2x2Artboard-1@2x2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Linkedin-ConcertAI-ASCO-2022-Reflections-scaled.jpgLinkedin-ConcertAI-ASCO-2022-Reflections-scaledLinkedin-ConcertAI-ASCO-2022-Reflections-scaledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ConcertAI-@-ASCO-2023-Front-Banner.svgConcertAI-@-ASCO-2023-Front-BannerConcertAI-@-ASCO-2023-Front-Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/WWW-World-Wide-Web.svgWWW-World-Wide-WebWWW-World-Wide-Webhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ASCO-Web-Banner-BG.pngASCO-Web-Banner-BGASCO-Web-Banner-BGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Unity-Together-Equality-1.svgUnity-Together-Equality-1Unity-Together-Equality-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-10@2x-2048x2048.pngArtboard-1-copy-10@2x-2048x2048Artboard-1-copy-10@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Asset-5.svgAsset-5Asset-5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Meet-With-Us-Button.pngMeet-With-Us-ButtonMeet-With-Us-Buttonhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy@2x2.pngArtboard-1-copy@2x2Artboard-1-copy@2x2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-12@2x-2048x2048.pngArtboard-1-copy-12@2x-2048x2048Artboard-1-copy-12@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study-Design.svgStudy-DesignStudy-Designhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-11@2x-2048x2048.pngArtboard-1-copy-11@2x-2048x2048Artboard-1-copy-11@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-15@2x.pngArtboard-1-copy-15@2xArtboard-1-copy-15@2xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-3@2x2.pngArtboard-1-copy-3@2x2Artboard-1-copy-3@2x2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-9@2x-2048x2048.pngArtboard-1-copy-9@2x-2048x2048Artboard-1-copy-9@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-2@2x2.pngArtboard-1-copy-2@2x2Artboard-1-copy-2@2x2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-6@2x2.pngArtboard-1-copy-6@2x2Artboard-1-copy-6@2x2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-14@2x-2048x2048.pngArtboard-1-copy-14@2x-2048x2048Artboard-1-copy-14@2x-2048x2048https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard-1-copy-8@2x-2048x2048.pngArtboard-1-copy-8@2x-2048x2048Artboard-1-copy-8@2x-2048x20482024-04-02https://www.concertai.com/news/2023/06/caris-life-sciences-and-concertai-expand-partnershiphttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/DSCF9644-Enhanced-NR-1024x682.jpgDSCF9644-Enhanced-NR-1024x682DSCF9644-Enhanced-NR-1024x682https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/IMG_0004-683x1024.jpgIMG_0004-683x1024IMG_0004-683x1024https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Caris-Partnership-Expansion-2_0-Social-1024x576.pngConcertAI-Caris-Partnership-Expansion-2_0-Social-1024x576ConcertAI-Caris-Partnership-Expansion-2_0-Social-1024x5762024-03-06https://www.concertai.com/publications/comparative-analysis-of-different-methods-of-disease-progression-data-capture-in-patients-with-metastatic-castration-resistant-prostate-cancer2026-08-18https://www.concertai.com/publications/computational-modeling-of-comprehensive-genomic-profiling-to-predict-chemotherapy-benefit-in-advanced-nsclc2026-08-18https://www.concertai.com/publications/outcomes-for-patients-with-mantle-cell-lymphoma-post-covalent-btk-inhibitor-therapy-in-the-united-states-and-japan-a-study-of-two-real-world-databases2026-08-18https://www.concertai.com/blog/2024/03/the-concertai-podcast-evolution-in-oncology-care-feat-george-sledge-phdhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Screenshot-2023-08-24-at-11_54_49-AM-1024x618.jpgScreenshot-2023-08-24-at-11_54_49-AM-1024x618Screenshot-2023-08-24-at-11_54_49-AM-1024x618https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/24FB9672-2CF3-4172-ADE2-C5D1ADD24FD7-2-1024x768.jpeg24FB9672-2CF3-4172-ADE2-C5D1ADD24FD7-2-1024x76824FB9672-2CF3-4172-ADE2-C5D1ADD24FD7-2-1024x768https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-32-2-1024x256.pngArtboard-1-copy-32-2-1024x256Artboard-1-copy-32-2-1024x256https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-25.pngArtboard-25Artboard-25https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/DSCF1273-Enhanced-NR-1024x683.jpgDSCF1273-Enhanced-NR-1024x683DSCF1273-Enhanced-NR-1024x683https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Screenshot-2023-08-24-at-11_53_33-AM-928x1024.jpgScreenshot-2023-08-24-at-11_53_33-AM-928x1024Screenshot-2023-08-24-at-11_53_33-AM-928x10242024-03-27https://www.concertai.com/publications/survival-outcomes-among-metastatic-castration-resistant-prostate-cancer-patients-treated-with-androgen-receptor-pathway-inhibitor-and-docetaxel2026-08-18https://www.concertai.com/blog/2023/04/the-concertai-podcast-the-future-of-digital-pathology-with-pathai-feat-dr-andy-beckhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Screen-Shot-2023-04-26-at-8_49_54-AM-2-1024x576-1.jpgScreen-Shot-2023-04-26-at-8_49_54-AM-2-1024x576-1Screen-Shot-2023-04-26-at-8_49_54-AM-2-1024x576-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Screen-Shot-2023-04-26-at-8_48_37-AM-2-1024x576-1.jpgScreen-Shot-2023-04-26-at-8_48_37-AM-2-1024x576-1Screen-Shot-2023-04-26-at-8_48_37-AM-2-1024x576-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-2-2.pngArtboard-1-copy-2-2Artboard-1-copy-2-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-17https://www.concertai.com/news/leading-nci-designated-cancer-centers-across-the-country-leverage-concertais-cancerlinq-to-support-personalized-evidence-based-quality-carehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PR-Leading%20NCI-Designated%20Cancer%20Center.pngPR-Leading NCI-Designated Cancer CenterPR-Leading NCI-Designated Cancer Centerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-05-28https://www.concertai.com/publications/real-world-effectiveness-and-treatment-patterns-of-venetoclax-based-regimens-among-patients-with-chronic-lymphocytic-leukemia-cll-treated-in-community-settings2026-08-18https://www.concertai.com/publications/real-world-clinical-outcomes-of-patients-with-metastatic-colorectal-cancer-mcrc-treated-with-trifluridine-tipiracil-plus-bevacizumab-by-performance-status2026-08-18https://www.concertai.com/publications/analysis-of-asco-clinical-guidelines-authorship-and-institutional-representation-using-hemonc-org2026-08-18https://www.concertai.com/publications/retrospective-analysis-of-real-world-management-of-egfr-mutated-advanced-nsclc-after-first-line-egfr-tki-treatment-us-treatment-patterns-attrition-and-survival-data2026-08-18https://www.concertai.com/external-control-arms/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Reduced%20Site%20and%20Patient%20Burden.svgReduced Site and Patient BurdenReduced Site and Patient Burdenhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Challenges.pngClinical Trial ChallengesClinical Trial Challengeshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Faster%20Drug%20Approvals.svgFaster Drug ApprovalsFaster Drug Approvalshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/External%20Control%20Arms.jpgExternal Control ArmsExternal Control Armshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Linked%20Claims%2c%20Genomics%20Datasets.svgLinked Claims, Genomics DatasetsLinked Claims, Genomics Datasetshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/img_data-products_data-counter@1.5x.jpgimg_data-products_data-counter@1.5ximg_data-products_data-counter@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Novel%20Study%20Designs.pngNovel Study DesignsNovel Study Designshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Custom%20Abstraction%20of%20Specific%20Variables.svgCustom Abstraction of Specific VariablesCustom Abstraction of Specific Variableshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Regulatory-Grade.svgRegulatory-GradeRegulatory-Gradehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Timely%20Treatment%20Assessments.svgTimely Treatment AssessmentsTimely Treatment Assessmentshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Full-Service%20Consultation.svgFull-Service ConsultationFull-Service Consultation2024-04-02https://www.concertai.com/publications/clinical-and-economic-impact-of-recurrence-in-early-stage-non-small-cell-lung-cancer-following-complete-resection2026-08-18https://www.concertai.com/blog/the-emerging-pharma-patient-compacthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lightning%20Strikes%20IV-%20Emergy%20Pharama-Patient%20Compat%20(3).pngConcertAI Blog - Lightning Strikes IV- Emergy Pharama-Patient Compat (3)ConcertAI Blog - Lightning Strikes IV- Emergy Pharama-Patient Compat (3)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2025-08-04https://www.concertai.com/publications/representativeness-of-race-ethnicity-and-social-determinants-of-health-in-patients-with-advanced-non-small-cell-lung-cancer-via-linkage-of-real-world-electronic2026-08-18https://www.concertai.com/publications/a-deep-learning-based-multimodal-integration-framework-for-clinical-outcome-prediction2026-08-18https://www.concertai.com/publications/electronic-clinical-quality-measure-ecqm-concordance-and-quality-care-disparities-among-patients-with-breast-cancer-bc2026-08-18https://www.concertai.com/publications/behavior-of-test-specificity-under-an-imperfect-gold-standard-findings-from-a-simulation-study-and-analysis-of-real-world-oncology-data2026-08-18https://www.concertai.com/blog/what-if-you-could-cut-clinical-trial-timelines-by-10-20-monthshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Blog%20-%2010-20%20Months%20Cut%20Timelines.pngBlog - 10-20 Months Cut TimelinesBlog - 10-20 Months Cut Timelineshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-05-06https://www.concertai.com/publications/real-world-outcomes-of-different-lines-and-sequences-of-treatment-in-braf-positive-advanced-melanoma-patients2026-08-18https://www.concertai.com/publications/invasive-disease-free-survival-as-a-surrogate-for-overall-survival-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor-receptor-22026-08-18https://www.concertai.com/publications/real-world-outcomes-with-adjuvant-nonsteroidal-aromatase-inhibitors-nsais-vs-tamoxifen-tam-in-patients-with-hormone-receptor-positive-human-epidermal-growth-factor2026-08-18https://www.concertai.com/study-design/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design.jpgStudy DesignStudy Designhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Nsclc.pngStudy Design NsclcStudy Design Nsclchttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Line%20Of%20Therapy.pngStudy Design Line Of TherapyStudy Design Line Of Therapyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Integration%20with%201st%20and%203rd%20Party%20Data.svgIntegration with 1st and 3rd Party DataIntegration with 1st and 3rd Party Datahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Time%20Savings.svgTime SavingsTime Savingshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Rapid%20Exploration%20of%20Large-Scale%20RWD.jpgRapid Exploration of Large-Scale RWDRapid Exploration of Large-Scale RWDhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Linkages%20to%20Claims%20Data.svgLinkages to Claims DataLinkages to Claims Datahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Stage.pngStudy Design StageStudy Design Stagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Stage%202.pngStudy Design Stage 2Study Design Stage 2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Funnel.pngStudy Design FunnelStudy Design Funnelhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Cost%20Savings.svgCost SavingsCost Savingshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Faster%20Time%20to%20Market.svgFaster Time to MarketFaster Time to Markethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Large%2c%20Independent%2c%20Deep%20Datasets.svgLarge, Independent, Deep DatasetsLarge, Independent, Deep Datasetshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Reduced%20time%20for%20study%20design.jpgReduced time for study designReduced time for study designhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/AI-Derived%20Variables%20for%20Scale%20and%20Validity.svgAI-Derived Variables for Scale and ValidityAI-Derived Variables for Scale and Validityhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Study%20Design%20Ecog.pngStudy Design EcogStudy Design Ecog2024-05-16https://www.concertai.com/publications/2024/03/treatment-patterns-and-effectiveness-outcomes-in-patients-with-relapsed-refractory-classical-hodgkins-lymphomahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/prevalence-and-distinct-biological-programs-of-small-cell-lung-cancer-molecular-subtypes-revealed-by-real-world-clinico-genomics-database2026-08-18https://www.concertai.com/blog/lighting-strikes-the-paradigm-shift-in-regulatory-aihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-12025-05-12https://www.concertai.com/publications/2024/03/development-of-an-algorithm-using-natural-language-processing-to-identify-metastatic-breast-cancer-patients-from-clinical-notes/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/clinical-outcomes-of-patients-with-metastatic-colorectal-cancer-treated-with-trifluridine-tipiracil-plus-bevacizumab-by-performance-status2026-08-18https://www.concertai.com/publications/real-world-progression-free-survival-and-treatment-patterns-for-t-11-14-positive-patients-with-multiple-myeloma-with-at-least-2-prior-lines-of-treatment2026-08-18https://www.concertai.com/news/2023/01/concertai-names-claudio-dambrosio-phd-as-its-first-chief-revenue-officerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Claudio-DAmbrosio-CRO-Announcement-v2-1024x536.pngClaudio-DAmbrosio-CRO-Announcement-v2-1024x536Claudio-DAmbrosio-CRO-Announcement-v2-1024x536https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2024-03-06https://www.concertai.com/publications/unlocking-insights-lesson-learned-from-the-tokenization-of-a-psoriasis-trial2026-08-18https://www.concertai.com/blog/2023/06/reflection-on-juneteenthhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Juneteenth-2023-1.pngJuneteenth-2023-1Juneteenth-2023-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-17https://www.concertai.com/publications/characteristics-treatment-patterns-and-outcomes-in-patients-with-high-risk-locally-advanced-cervical-cancer2026-08-18https://www.concertai.com/publications/real-world-clinical-outcomes-among-patients-with-non-squamous-advanced-non-small-cell-lung-cancer-ansclc-treated-with-docetaxel-based-regimens-post-initial-standard-of2026-08-18https://www.concertai.com/blog/2023/06/going-beyond-binaryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Pride-Month-2023-1.pngPride-Month-2023-1Pride-Month-2023-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Pride-Month-2023-1024x1024-1.pngPride-Month-2023-1024x1024-1Pride-Month-2023-1024x1024-12024-03-17https://www.concertai.com/publications/real-world-outcomes-in-metastatic-hr-plus-her2-her2-plus-and-triple-negative-breast-cancer-after-start-of-first-line-therapy2026-08-18https://www.concertai.com/publications-oldhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_5.pngCON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_5CON_CY26_ConcertAI_BrandIdentity_SecondaryGraphics_Overall_5https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-and-sequencing-in-patients-with-locally-advanced-or-metastatic-urothelial-cancer-la-muc-in-the-us2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-of-adjuvant-endocrine-therapy-and-ovarian-suppression-in-premenopausal-hr-plus-her2-plus-breast-cancer-20222026-08-18https://www.concertai.com/news/concertai-appoints-shawn-w.-bates-as-general-manager-commercial-solutionshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Shawn%20W%20Bates%20PR%20Post.pngShawn W Bates PR PostShawn W Bates PR Posthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-05-12https://www.concertai.com/publicationshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Cover%202%20(1).pngConcertAI Cover 2 (1)ConcertAI Cover 2 (1)2026-08-18https://www.concertai.com/patient360-new-factsheet/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/blog/2023/02/the-concertai-podcast-trial-diversity-feat-warren-whytehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PM.pngConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMConcertAI-Podcast-Cover-Mar-17-2024-02-32-50-2063-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PM.pngConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PMConcertAI-Podcast-Banner-Plug-Mar-17-2024-02-32-42-7815-PMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Warren-Whyte-on-The-ConcertAI-Podcast-1.jpgWarren-Whyte-on-The-ConcertAI-Podcast-1Warren-Whyte-on-The-ConcertAI-Podcast-12024-03-17https://www.concertai.com/publications/proportional-randomization-method-to-identify-index-line-of-therapy-in-externally-controlled-trials2026-08-18https://www.concertai.com/publications/2024/03/development-of-an-artificial-intelligence-model-to-predict-survival-at-specific-time-intervals-for-lung-cancer-patients/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-02https://www.concertai.com/publications/real-world-characteristics-treatment-modifications-and-outcomes-for-patients-with-acute-myeloid-leukemia-aml-receiving-hypomethylating-agents-hma-plus-venetoclax-ven-as2026-08-18https://www.concertai.com/publications/challenges-in-analyzing-real-world-evidence-analysis-of-androgen-deprivation-therapy-use-for-prostate-cancer-in-the-reassure-study2026-08-18https://www.concertai.com/publications/real-world-treatment-patterns-among-advanced-non-small-cell-lung-cancer-patients-in-the-us2026-08-18https://www.concertai.com/publications/kras-co-mutational-landscape-dictates-treatment-outcomes-in-pancreatic-cancer-pc-patients2026-08-18https://www.concertai.com/publications/chart-review-study-on-the-real-world-cytopenia-management-of-patients-with-acute-myeloid-leukemia-treated-with-venetoclax-and-hypomethylating-agents2026-08-18https://www.concertai.com/blog/2024/02/real-world-data-and-evidence-driven-decisions-save-lives-start-psa-screening-earlier-in-black-menhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/ConcertAI-Blog-Posts-PSA-blog-1.pngConcertAI-Blog-Posts-PSA-blog-1ConcertAI-Blog-Posts-PSA-blog-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/230343_A574_poster_big_1-1024x768-1.jpg230343_A574_poster_big_1-1024x768-1230343_A574_poster_big_1-1024x768-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-27https://www.concertai.com/publications/efficient-site-selection-for-clinical-trials-using-simulated-annealing2026-08-18https://www.concertai.com/newshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PR-Leading%20NCI-Designated%20Cancer%20Center.pngPR-Leading NCI-Designated Cancer CenterPR-Leading NCI-Designated Cancer Centerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Social/Missy%20Jerome%20PR%20(1).pngMissy Jerome PR (1)Missy Jerome PR (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Shawn%20W%20Bates%20PR%20Post.pngShawn W Bates PR PostShawn W Bates PR Posthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20and%20Foundation%20Medicine%20Integrate%20Genomic%20and%20Clinical%20Data%20to%20Transform%20Translational%20Research%20and%20Efficient%20Drug%20Development.pngConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug DevelopmentConcertAI and Foundation Medicine Integrate Genomic and Clinical Data to Transform Translational Research and Efficient Drug Developmenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Press%20Release%20ConcertAI%20Launches%20Accelerated%20Clinical%20Trials%2c%20Leveraging%20Agentic%20AI%20to%20Streamline%20Trial%20Timelines.pngConcertAI Press Release ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Streamline Trial TimelinesConcertAI Press Release ConcertAI Launches Accelerated Clinical Trials, Leveraging Agentic AI to Streamline Trial Timelineshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PR-Expands%20CancerLinQ%20Suite%20(2).pngPR-Expands CancerLinQ Suite (2)PR-Expands CancerLinQ Suite (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/img-hero-news@1.5x.jpgimg-hero-news@1.5ximg-hero-news@1.5xhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Social/ConcertAI%20Press%20Release%20ConcertAI%20Launches%20Cadence%20Suite-3.pngConcertAI Press Release ConcertAI Launches Cadence Suite-3ConcertAI Press Release ConcertAI Launches Cadence Suite-32026-05-28https://www.concertai.com/publications/real-world-outcomes-in-patients-with-egfr-wildtype-non-squamous-locally-advanced-metastatic-nsclc-receiving-second-or-third-line-docetaxel-pooled-analysis-from2026-08-18https://www.concertai.com/precision-trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials_4K.mp4/medium.jpgPrecision Trials_4KPrecision Trials_4Khttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials_4K.mp487nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Improved%20Enrollment.svgImproved EnrollmentImproved Enrollmenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Speed%20(Blue).svgSpeed (Blue)Speed (Blue)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cohort%20Builder%20Agent.pngCohort Builder AgentCohort Builder Agenthttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision360%20Social%20SQ%20(1).pngPrecision360 Social SQ (1)Precision360 Social SQ (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20Banner.pngPrecision Trials BannerPrecision Trials Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Study%20Design%20Agent%20(NEW).pngStudy Design Agent (NEW)Study Design Agent (NEW)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Sites%20(Blue).svgSites (Blue)Sites (Blue)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/efficiency.svgefficiencyefficiencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision%20Trials%20WWO.pngPrecision Trials WWOPrecision Trials WWOhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Cohort%20Exploration%20Agent%20(NEW).pngCohort Exploration Agent (NEW)Cohort Exploration Agent (NEW)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Site%20Selection%20Agent%20(NEW).pngSite Selection Agent (NEW)Site Selection Agent (NEW)2025-08-28https://www.concertai.com/request-a-clinical-trial-optimization-demo/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.pngClinical Trial OptimizationClinical Trial Optimization2024-03-27https://www.concertai.com/publications/treatment-patterns-and-outcomes-among-locally-advanced-cervical-cancer-patients-receiving-concurrent-chemoradiotherapy2026-08-18https://www.concertai.com/data-foundryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Multi-Partner%20Data-1.pngSDA - Multi-Partner Data-1SDA - Multi-Partner Data-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Market%20Access-1.pngSDA - Market Access-1SDA - Market Access-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_10.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_10CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_Commercial_10https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Contract%20Compliance%20Tracking-1.pngSDA - Contract Compliance Tracking-1SDA - Contract Compliance Tracking-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/SDA%20-%20Speed-2.pngSDA - Speed-2SDA - Speed-2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/DATA%20FOUNDRY%20IMG.pngDATA FOUNDRY IMGDATA FOUNDRY IMG2026-05-28https://www.concertai.com/publications/amivantamab-compared-with-real-world-therapies-in-patients-with-advanced-non-small-cell-lung-cancer-harboring-egfr-exon-20-insertion-mutations-who-progressed-after2026-08-18https://www.concertai.com/escreening-for-sponsors-fact-sheethttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Fact-Sheet-Display_eScreening-Sponsors.pngFact-Sheet-Display_eScreening-SponsorsFact-Sheet-Display_eScreening-Sponsorshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-04-01https://www.concertai.com/publications/real-world-management-and-outcomes-for-newly-diagnosed-aml-patients-initiating-venetoclax-and-hypomethylating-agents-in-us-community-practice2026-08-18https://www.concertai.com/publications/real-world-outcomes-following-ibrutinib-dose-reduction-in-patients-with-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma2026-08-18https://www.concertai.com/news/how-concertai-turned-cancerlinq-into-a-point-of-care-oncology-intelligence-platformhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo new2026-07-29https://www.concertai.com/publications/racial-disparities-in-clinical-trial-enrollment-among-patients-diagnosed-with-prostate-cancer-a-population-based-cohort-of-oncology-practices2026-08-18https://www.concertai.com/patientlinqhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Fully%20Embedded.svgFully EmbeddedFully Embeddedhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PatientLinQ%20Banner.pngPatientLinQ BannerPatientLinQ Bannerhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PatientLinQ%20Cover.pngPatientLinQ CoverPatientLinQ Coverhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Efficiency.svgEfficiencyEfficiencyhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/PatientLinQ%20Suite%20Social%20SQ.pngPatientLinQ Suite Social SQPatientLinQ Suite Social SQhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Precision.svgPrecisionPrecisionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/concertai-logo.svgconcertai-logoconcertai-logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Continuously%20Learning.svgContinuously LearningContinuously Learning2025-05-29https://www.concertai.com/events/webinar-technology-and-ai-innovation-in-clinical-trials-recruitment-and-execution/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Imperative%20Redoubled.pngConcertAI Blog - Imperative RedoubledConcertAI Blog - Imperative Redoubledhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Blog%20-%20Lighting%20Strikes-1.pngConcertAI Blog - Lighting Strikes-1ConcertAI Blog - Lighting Strikes-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-192024-03-26https://www.concertai.com/publications/clinical-outcomes-with-alpelisib-alp-plus-fulvestrant-ful-after-prior-treatment-tx-with-ful-in-patients-pts-with-advanced-breast-cancer-abc-a-real-world-rw-analysis2026-08-18https://www.concertai.comhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop01-01-ConcertAi.mp4/medium.jpgCAI-BGLoop01-01-ConcertAiCAI-BGLoop01-01-ConcertAihttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CAI-BGLoop01-01-ConcertAi.mp424nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/abbvie.svgabbvieabbviehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Mayo%20Clinic%20Home%20Page.svgMayo Clinic Home PageMayo Clinic Home Pagehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Blog%20From%20orchestration%20to%20discovery%20ConcertAI%2c%20NVIDIA%2c%20and%20what%20comes%20next%20with%20BioNeMo.pngBlog From orchestration to discovery ConcertAI, NVIDIA, and what comes next with BioNeMoBlog From orchestration to discovery ConcertAI, NVIDIA, and what comes next with BioNeMohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Logo%20of%20University%20of%20Maryland%20Medical%20Center%20(1).svgLogo of University of Maryland Medical Center (1)Logo of University of Maryland Medical Center (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Cover%202%20(1).pngConcertAI Cover 2 (1)ConcertAI Cover 2 (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amgen%20Logo%20White.svgAmgen Logo WhiteAmgen Logo Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/logo-atrium-white-svg.svglogo-atrium-white-svglogo-atrium-white-svghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NeoGenomics.svg.pngNeoGenomics.svgNeoGenomics.svghttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Nvidia_logo.svgNvidia_logoNvidia_logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Merck%20(White).svgMerck (White)Merck (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Otsuka_Holdings_logo%20(White).svgOtsuka_Holdings_logo (White)Otsuka_Holdings_logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Regeneron.svgRegeneronRegeneronhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/AstraZeneca.svgAstraZenecaAstraZenecahttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Microsoft%20Teams%20Background%20v8-1.pngMicrosoft Teams Background v8-1Microsoft Teams Background v8-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Penn%20Medicine%20Home.svgPenn Medicine HomePenn Medicine Homehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Artboard%201-1.pngArtboard 1-1Artboard 1-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Nebras%20H%20Lo%20(Whi).svgNebras H Lo (Whi)Nebras H Lo (Whi)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Geisinger%20Logo.svgGeisinger LogoGeisinger Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Healthcare%20intelligence%20(1).pngHealthcare intelligence (1)Healthcare intelligence (1)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Astellas%20White.svgAstellas WhiteAstellas Whitehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Lilly%20Logo%20(White).svgLilly Logo (White)Lilly Logo (White)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Artboard%202-1.pngArtboard 2-1Artboard 2-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Amazon_Web_Services_Logo.svgAmazon_Web_Services_LogoAmazon_Web_Services_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/283366%20ConcertAI%20(2)%20-%202026%20Fast%20Company%20Most%20Innovative%20Companies%20-%20Custom%20Logo-1.png283366 ConcertAI (2) - 2026 Fast Company Most Innovative Companies - Custom Logo-1283366 ConcertAI (2) - 2026 Fast Company Most Innovative Companies - Custom Logo-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Temple%20Health%20Logo%20(2).svgTemple Health Logo (2)Temple Health Logo (2)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/NHS%20England.svgNHS EnglandNHS Englandhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Guardant%20Health.svgGuardant HealthGuardant Healthhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/duke_logo.svgduke_logoduke_logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Foundation%20Medicine%20Logo.svgFoundation Medicine LogoFoundation Medicine Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CarisLS_Color_Primary_Logo.webpCarisLS_Color_Primary_LogoCarisLS_Color_Primary_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI%20Commercial%20(1).pngConcertAI Commercial (1)ConcertAI Commercial (1)2026-06-30https://www.concertai.com/blog/2023/07/trustworthy-clinical-trialshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-1-copy-23_1-1.pngArtboard-1-copy-23_1-1Artboard-1-copy-23_1-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Artboard-16_2-1024x268-1.pngArtboard-16_2-1024x268-1Artboard-16_2-1024x268-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-17https://www.concertai.com/publications/quantitating-and-assessing-interoperability-between-electronic-health-records2026-08-18https://www.concertai.com/news/2024/01/concertai-highlights-2024-partnerships-strategy-business-results-and-ai-roadmap-at-42nd-annual-j-p-morgan-healthcare-conferencehttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Imported_Blog_Media/Business-Insider-25-Healthcare-Startups-1.pngBusiness-Insider-25-Healthcare-Startups-1Business-Insider-25-Healthcare-Startups-1https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logo2024-03-06https://www.concertai.com/scientific-serviceshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp4/medium.jpgtr_rsna_2024 (2160p)tr_rsna_2024 (2160p)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/tr_rsna_2024%20(2160p).mp497nonohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/ConcertAI_Logo.svgConcertAI_LogoConcertAI_Logohttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_2.pngCON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_2CON_CY26_ConcertAI_BrandIdentity_KeyGraphics_RWE_2https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/white%20logo%20new.svgwhite logo newwhite logo newhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Scientific%20Services%20V1.pngScientific Services V1Scientific Services V12026-05-28https://www.concertai.com/publications/health-data-sharing-perspectives-of-patients-receiving-care-in-cancerlinq-participating-oncology-practices2026-08-18https://www.concertai.com/publications/multi-modal-real-world-data-uncovers-predictors-of-clinical-response-to-top1i-and-optimizes-adc-strategies-in-colorectal-cancer2026-08-18https://www.concertai.com/concertai-neogenomics/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Sponsors).jpgDigital Trial Solutions (Sponsors)Digital Trial Solutions (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ORAL%20PRESENTATION%20WITH%20ABBVIE..pngORAL PRESENTATION WITH ABBVIE.ORAL PRESENTATION WITH ABBVIE.https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Artboard.pngArtboardArtboardhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Compare%20Characteristics%20of%20Patients%20to%20Clinical%20Trials%20and%20Follow-up%20on%20Outcomes.svgCompare Characteristics of Patients to Clinical Trials and Follow-up on OutcomesCompare Characteristics of Patients to Clinical Trials and Follow-up on Outcomeshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ASH%20ANNUAL%20MEETING.pngASH ANNUAL MEETINGASH ANNUAL MEETINGhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Clinical%20Trial%20Optimization.jpgClinical Trial OptimizationClinical Trial Optimizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ASH%202023%20Web.pngASH 2023 WebASH 2023 Webhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Neo-Image-for-Web.pngNeo-Image-for-WebNeo-Image-for-Webhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Assess%20Racial%20Disparities%20in%20Treatment%20Patterns%20and%20Outcomes%20at%20the%20Molecular%20Level.svgAssess Racial Disparities in Treatment Patterns and Outcomes at the Molecular LevelAssess Racial Disparities in Treatment Patterns and Outcomes at the Molecular Levelhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Digital%20Trial%20Solutions%20(Providers).jpgDigital Trial Solutions (Providers)Digital Trial Solutions (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Explore%20Real-World%20Patient%20and%20Testing%20Journeys%20and%20Heme%20Healthcare%20Utilization.svgExplore Real-World Patient and Testing Journeys and Heme Healthcare UtilizationExplore Real-World Patient and Testing Journeys and Heme Healthcare Utilizationhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Research%20Progostic%20Value%20of%20Cytogenetics%20in%20Relapsed%20(Refractory)%20Patients%20Exposed%20to%20Specific%20Therapies.svgResearch Progostic Value of Cytogenetics in Relapsed (Refractory) Patients Exposed to Specific TherapiesResearch Progostic Value of Cytogenetics in Relapsed (Refractory) Patients Exposed to Specific Therapieshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Dynamic%20RWE%20Registry.jpgDynamic RWE RegistryDynamic RWE Registryhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Genome360TM.jpgGenome360TMGenome360TMhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ONLINE%20ONLY%20PUBLICATION.pngONLINE ONLY PUBLICATIONONLINE ONLY PUBLICATIONhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/POSTER%20PRESENTATION%20WITH%20ABBVIE.pngPOSTER PRESENTATION WITH ABBVIEPOSTER PRESENTATION WITH ABBVIEhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/ECA%20for%20Regulatory%20Submission.jpgECA for Regulatory SubmissionECA for Regulatory Submissionhttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/RWD360%C2%AE.jpgRWD360®RWD360®https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Providers).jpgeScreening (Providers)eScreening (Providers)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/eScreening%20(Sponsors).jpgeScreening (Sponsors)eScreening (Sponsors)https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Predict%20Risk%20Scores%20and%20Survival%20Using%20Comprehensive%20Testing%20Combined%20with%20Clinical%20Results.svgPredict Risk Scores and Survival Using Comprehensive Testing Combined with Clinical ResultsPredict Risk Scores and Survival Using Comprehensive Testing Combined with Clinical Resultshttps://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Patient360TM.jpgPatient360TMPatient360TM2024-12-17https://www.concertai.com/publications/-epidemiology-of-met-gene-mrna-expression-in-metastatic-colorectal-cancer-analyses-of-a-real-world-clinicogenomic-database2026-08-18https://www.concertai.com/publications/demographics-clinical-characteristics-treatment-patterns-and-clinical-outcomes-of-patients-with-stages-i-iii-resected-nsclc-without-known-egfr-mutations2026-08-18https://www.concertai.com/request-a-data-count/https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/svgexport-19.svgsvgexport-19svgexport-19https://536501.fs1.hubspotusercontent-na1.net/hubfs/536501/Concertai_March2024/images/Request%20Data%20Count.jpgRequest Data CountRequest Data Count2024-03-27https://www.concertai.com/publications/case-studies-for-overcoming-challenges-in-using-big-data-in-cancer2026-08-18https://www.concertai.com/publications/identifying-co-mutational-signatures-in-stk11-mutated-advanced-non-small-cell-lung-cancer-ansclc-patients-that-help-overcome-poor-response-to-immune-checkpoint2026-08-18